<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Aspirin,Aspirin.png,Analgesics,NSAIDs,NSAIDs,Analgesics,Opioids,1899,1971,1982,ATC code A01" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Aspirin - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Aspirin</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    	    <!-- start content -->
	    <dl>
<dd><i>For the author, see <a href="../../../r/o/b/Robert_Asprin_bbe5.html" title="Robert Asprin">Robert Asprin</a>.</i></dd>
</dl>
<table id="drugInfoBox" style="float: right; clear: right; margin: 0 0 0.5em 1em; background: #ffffff;" class="toccolours" border="0" cellpadding="1" align="right" width="280">
<tr>
<td align="center" colspan="2"><a href="../../../a/s/p/Image%7EAspirin-skeletal.svg_c73f.html" class="image" title=""><img src="../../../upload/shared/thumb/6/67/Aspirin-skeletal.svg/125px-Aspirin-skeletal.svg.png" alt="" width="125" height="104" longdesc="../../../a/s/p/Image%7EAspirin-skeletal.svg_c73f.html" /></a></td>
</tr>
<tr>
<td align="center" colspan="2"><a href="../../../a/s/p/Image%7EAspirin-3D-vdW.png_ab6f.html" class="image" title=""><img src="../../../upload/shared/thumb/d/dc/Aspirin-3D-vdW.png/125px-Aspirin-3D-vdW.png" alt="" width="125" height="124" longdesc="../../../a/s/p/Image%7EAspirin-3D-vdW.png_ab6f.html" /></a></td>
</tr>
<tr>
<td align="center" colspan="2">
<div style="font-size:medium; line-height:167%;">Aspirin</div>
</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Systematic (<a href="../../../i/n/t/International_Union_of_Pure_and_Applied_Chemistry_nomenclature_efd4.html" title="International Union of Pure and Applied Chemistry nomenclature">IUPAC</a>) name</b></td>
</tr>
<tr>
<td bgcolor="#EEEEEE" style="text-align: center; vertical-align: top;" colspan="2"><span style="font-size:11px">2-acetoxybenzoic acid</span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Identifiers</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" width="90"><a href="../../../c/a/s/CAS_registry_number_4b20.html" title="CAS registry number">CAS number</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.nlm.nih.gov/cgi/mesh/2006/MB_cgi?term=50-78-2&amp;rn=1" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2006/MB_cgi?term=50-78-2&amp;rn=1" rel="nofollow">50-78-2</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../a/n/a/Anatomical_Therapeutic_Chemical_Classification_System_186e.html" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></td>
<td bgcolor="#EEEEEE"><a href="../../../a/t/c/ATC_code_A01_0709.html" title="ATC code A01">A01</a><span class="reflink plainlinksneverexpand"><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=A01AD05" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=A01AD05" rel="nofollow">AD05</a></span> <a href="../../../a/t/c/ATC_code_B01_f871.html" title="ATC code B01">B01</a><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=B01AC06" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=B01AC06" rel="nofollow">AC06</a>, <a href="../../../a/t/c/ATC_code_N02_38b2.html" title="ATC code N02">N02</a><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=N02BA01" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=N02BA01" rel="nofollow">BA01</a></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../p/u/b/PubChem_a50b.html" title="PubChem">PubChem</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=2244" class="external text" title="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=2244" rel="nofollow">2244</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../d/r/u/DrugBank_2050.html" title="DrugBank">DrugBank</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://redpoll.pharmacy.ualberta.ca/drugbank/cgi-bin/getCard.cgi?CARD=APRD00264" class="external text" title="http://redpoll.pharmacy.ualberta.ca/drugbank/cgi-bin/getCard.cgi?CARD=APRD00264" rel="nofollow">APRD00264</a></span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Chemical data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../c/h/e/Chemical_formula.html" title="Chemical formula">Formula</a></td>
<td bgcolor="#EEEEEE"><a href="../../../c/a/r/Carbon.html" title="Carbon"><span style="color: rgb(000,000,000); font-weight: bold;">C</span></a><sub>9</sub><a href="../../../h/y/d/Hydrogen.html" title="Hydrogen"><span style="color: rgb(77,77,77); font-weight: bold;">H</span></a><sub>8</sub><a href="../../../o/x/y/Oxygen.html" title="Oxygen"><span style="color: rgb(116,35,35); font-weight: bold;">O</span></a><sub>4</sub><sup>&#160;</sup></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../m/o/l/Molecular_mass.html" title="Molecular mass">Mol. mass</a></td>
<td bgcolor="#EEEEEE">180.160 g/mol</td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../s/i/m/Simplified_molecular_input_line_entry_specification.html" title="Simplified molecular input line entry specification">SMILES</a></td>
<td bgcolor="#EEEEEE">search in <span class="reflink plainlinksneverexpand"><a href="http://www.emolecules.com/cgi-bin/search?t=ss&amp;q=CC%28%3DO%29Oc1ccccc1C%28%3DO%29O" class="external text" title="http://www.emolecules.com/cgi-bin/search?t=ss&amp;q=CC%28%3DO%29Oc1ccccc1C%28%3DO%29O" rel="nofollow">eMolecules</a></span>, <span class="reflink plainlinksneverexpand"><a href="http://pubchem.ncbi.nlm.nih.gov/search/?smarts=CC%28%3DO%29Oc1ccccc1C%28%3DO%29O" class="external text" title="http://pubchem.ncbi.nlm.nih.gov/search/?smarts=CC%28%3DO%29Oc1ccccc1C%28%3DO%29O" rel="nofollow">PubChem</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../s/y/n/Synonym.html" title="Synonym">Synonyms</a></td>
<td bgcolor="#EEEEEE">2-acetyloxybenzoic acid<br />
2-(acetyloxy)benzoic acid<br />
acetylsalicylate<br />
acetylsalicylic acid<br />
O-acetylsalicylic acid</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Physical data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../d/e/n/Density.html" title="Density">Density</a></td>
<td bgcolor="#EEEEEE">1.40&#160;g/cm³</td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../m/e/l/Melting_point.html" title="Melting point">Melt. point</a></td>
<td bgcolor="#EEEEEE">138–140&#160;°C (280–284&#160;°F)</td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../b/o/i/Boiling_point.html" title="Boiling point">Boiling point</a></td>
<td bgcolor="#EEEEEE">140&#160;°C (284&#160;°F) (decomposes)</td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../s/o/l/Solubility.html" title="Solubility">Solubility</a> in <a href="../../../w/a/t/Water_%28molecule%29.html" title="Water (molecule)">water</a></td>
<td bgcolor="#EEEEEE">1&#160;mg/mL (20&#160;°C)</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Pharmacokinetic data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../b/i/o/Bioavailability.html" title="Bioavailability">Bioavailability</a></td>
<td bgcolor="#EEEEEE">rapid &amp; complete</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../p/l/a/Plasma_protein_binding.html" title="Plasma protein binding">Protein binding</a></td>
<td bgcolor="#EEEEEE">99.6%</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../d/r/u/Drug_metabolism.html" title="Drug metabolism">Metabolism</a></td>
<td bgcolor="#EEEEEE"><a href="../../../l/i/v/Liver.html" title="Liver">Hepatic</a></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../b/i/o/Biological_half-life.html" title="Biological half-life">Half life</a></td>
<td bgcolor="#EEEEEE">300–650 mg dose: 3.1–3.2hrs<br />
1 g dose: 5 hours<br />
2 g dose: 9 hours</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../e/x/c/Excretion.html" title="Excretion">Excretion</a></td>
<td bgcolor="#EEEEEE"><a href="../../../k/i/d/Kidney.html" title="Kidney">Renal</a></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Therapeutic considerations</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../p/r/e/Pregnancy_category.html" title="Pregnancy category">Pregnancy cat.</a></td>
<td bgcolor="#EEEEEE">
<p>C<small>(<a href="../../../a/u/s/Australia.html" title="Australia">AU</a>)</small> C<small>(<a href="../../../u/n/i/United_States_09d4.html" title="United States">US</a>)</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../r/e/g/Regulation_of_therapeutic_goods.html" title="Regulation of therapeutic goods">Legal status</a></td>
<td bgcolor="#EEEEEE">
<p>U<small>nscheduled</small><small>(<a href="../../../a/u/s/Australia.html" title="Australia">AU</a>)</small> GSL<small>(<a href="../../../u/n/i/United_Kingdom_5ad7.html" title="United Kingdom">UK</a>)</small> <a href="../../../o/v/e/Over_the_counter.html" title="Over the counter">OTC</a><small>(<a href="../../../u/n/i/United_States_09d4.html" title="United States">US</a>)</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../r/o/u/Route_of_administration.html" title="Route of administration">Routes</a></td>
<td bgcolor="#EEEEEE">oral</td>
</tr>
</table>
<p><b>Aspirin</b>, or <b>acetylsalicylic acid</b> (<a href="../../../i/n/t/International_Phonetic_Alphabet_96f8.html" title="International Phonetic Alphabet">IPA</a>: <span title="Pronunciation in IPA" class="IPA">[əˈsɛtlˌsæləˈsɪlɪk ˈæsɪd]</span>), (acetosal) is a <a href="../../../m/e/d/Medication.html" title="Medication">drug</a> in the family of <a href="../../../s/a/l/Salicylate.html" title="Salicylate">salicylates</a>, often used as an <a href="../../../a/n/a/Analgesic.html" title="Analgesic">analgesic</a> (to relieve minor aches and pains), <a href="../../../a/n/t/Antipyretic.html" title="Antipyretic">antipyretic</a> (to reduce <a href="../../../f/e/v/Fever.html" title="Fever">fever</a>), and as an anti-<a href="../../../i/n/f/Inflammation.html" title="Inflammation">inflammatory</a>. It also has an <a href="../../../a/n/t/Antiplatelet_drug.html" title="Antiplatelet drug">antiplatelet</a> ("blood-thinning") effect and is used in long-term, low doses to prevent <a href="../../../m/y/o/Myocardial_infarction.html" title="Myocardial infarction">heart attacks</a> and <a href="../../../c/a/n/Cancer.html" title="Cancer">cancer</a>.</p>
<p>Low-dose, long-term aspirin use <a href="../../../r/e/v/Reversible_reaction.html" title="Reversible reaction">irreversibly blocks</a> the formation of <a href="../../../t/h/r/Thromboxane.html" title="Thromboxane">thromboxane</a> A<sub>2</sub> in <a href="../../../p/l/a/Platelet.html" title="Platelet">platelets</a>, producing an inhibitory effect on <a href="../../../p/l/a/Platelet.html" title="Platelet">platelet aggregation</a>. This anticoagulant property makes it useful for reducing the incidence of heart attacks. Aspirin produced for this purpose often comes in 75 or 81 <a href="../../../m/i/l/Milligram.html" title="Milligram">mg</a>, dispersible <a href="../../../t/a/b/Tablet.html" title="Tablet">tablets</a> and is sometimes called "junior aspirin" or "baby aspirin." New evidence suggests that baby aspirin may not be as effective in preventing heart attacks and cerebrovascular accidents as previously thought. High doses of aspirin are also given immediately after an acute heart attack. These doses may also inhibit the synthesis of <a href="../../../p/r/o/Prothrombin.html" title="Prothrombin">prothrombin</a> and may, therefore, produce a second and different anticoagulant effect, but this is not well understood.</p>
<p>Its primary, undesirable side effects, especially in higher doses, are <a href="../../../g/a/s/Gastrointestinal.html" title="Gastrointestinal">gastrointestinal</a> distress (including <a href="../../../g/a/s/Gastric_ulcer.html" title="Gastric ulcer">ulcers</a> and stomach bleeding) and <a href="../../../t/i/n/Tinnitus.html" title="Tinnitus">tinnitus</a>. Another side effect, due to its anticoagulant properties, is increased bleeding in <a href="../../../m/e/n/Menstruating.html" title="Menstruating">menstruating</a> women. Because there appears to be a connection between aspirin and <a href="../../../r/e/y/Reye%27s_syndrome.html" title="Reye's syndrome">Reye's syndrome</a>, aspirin is no longer used to control <a href="../../../i/n/f/Influenza.html" title="Influenza">flu</a>-like symptoms or the symptoms of chickenpox in minors.<sup id="_ref-BMJ2002-Macdonald_0" class="reference"><a href="#_note-BMJ2002-Macdonald" title="">[1]</a></sup></p>
<p>Aspirin was the first-discovered member of the class of drugs known as non-steroidal, anti-inflammatory drugs (<a href="../../../n/s/a/NSAID_a6d3.html" title="NSAID">NSAIDs</a>), not all of which are salicylates, though they all have similar effects and a similar action mechanism.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Aspirin_as_genericized_trademark"><span class="tocnumber">1</span> <span class="toctext">Aspirin as genericized trademark</span></a></li>
<li class="toclevel-1"><a href="#Discovery"><span class="tocnumber">2</span> <span class="toctext">Discovery</span></a></li>
<li class="toclevel-1"><a href="#Synthesis_of_aspirin"><span class="tocnumber">3</span> <span class="toctext">Synthesis of aspirin</span></a></li>
<li class="toclevel-1"><a href="#Mechanism_of_action"><span class="tocnumber">4</span> <span class="toctext">Mechanism of action</span></a></li>
<li class="toclevel-1"><a href="#Indications"><span class="tocnumber">5</span> <span class="toctext">Indications</span></a>
<ul>
<li class="toclevel-2"><a href="#Dosage"><span class="tocnumber">5.1</span> <span class="toctext">Dosage</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Toxicity_of_low-dose_aspirin"><span class="tocnumber">6</span> <span class="toctext">Toxicity of low-dose aspirin</span></a></li>
<li class="toclevel-1"><a href="#Contraindications_and_warnings"><span class="tocnumber">7</span> <span class="toctext">Contraindications and warnings</span></a></li>
<li class="toclevel-1"><a href="#Common_side-effects"><span class="tocnumber">8</span> <span class="toctext">Common side-effects</span></a></li>
<li class="toclevel-1"><a href="#Interactions"><span class="tocnumber">9</span> <span class="toctext">Interactions</span></a></li>
<li class="toclevel-1"><a href="#Overdose"><span class="tocnumber">10</span> <span class="toctext">Overdose</span></a>
<ul>
<li class="toclevel-2"><a href="#Symptoms"><span class="tocnumber">10.1</span> <span class="toctext">Symptoms</span></a></li>
<li class="toclevel-2"><a href="#Toxicity"><span class="tocnumber">10.2</span> <span class="toctext">Toxicity</span></a></li>
<li class="toclevel-2"><a href="#Treatment"><span class="tocnumber">10.3</span> <span class="toctext">Treatment</span></a></li>
<li class="toclevel-2"><a href="#Epidemiology"><span class="tocnumber">10.4</span> <span class="toctext">Epidemiology</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Research_into_cancer_prevention"><span class="tocnumber">11</span> <span class="toctext">Research into cancer prevention</span></a></li>
<li class="toclevel-1"><a href="#Aspirin_in_pets"><span class="tocnumber">12</span> <span class="toctext">Aspirin in pets</span></a></li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">13</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">14</span> <span class="toctext">External links</span></a></li>
<li class="toclevel-1"><a href="#Footnotes"><span class="tocnumber">15</span> <span class="toctext">Footnotes</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Aspirin_as_genericized_trademark" id="Aspirin_as_genericized_trademark"></a></p>
<h2><span class="editsection">[<a href="../../../a/s/p/Aspirin.html" title="Edit section: Aspirin as genericized trademark">edit</a>]</span> <span class="mw-headline">Aspirin as genericized trademark</span></h2>
<p>The brand name <i>Aspirin</i> was coined by the <a href="../../../b/a/y/Bayer.html" title="Bayer">Bayer</a> company of <a href="../../../g/e/r/Germany.html" title="Germany">Germany</a>. In some countries the name is used as a <a href="../../../g/e/n/Genericized_trademark.html" title="Genericized trademark">generic term</a> for the drug rather than the manufacturer's <a href="../../../t/r/a/Trademark.html" title="Trademark">trademark</a>. In countries in which Aspirin remains a trademark, the <a href="../../../i/n/i/Initialism.html" title="Initialism">initialism</a> <b>ASA</b> (for <i>acetylsalicylic acid</i>) is used as a generic term.</p>
<p>The name "aspirin" is composed of <i>a-</i> (from the <a href="../../../a/c/e/Acetyl_group.html" title="Acetyl group">acetyl group</a>) <i>-spir-</i> (from the plant genus <i><a href="../../../s/p/i/Spiraea.html" title="Spiraea">Spiraea</a></i>) and <i>-in</i> (a common ending for drugs at the time). It has also been stated that the name originated by another means. "As" referring to AcetylSalicylic and "pir" in reference to one of the scientists who was able to isolate it in crystalline form, Raffaele Piria. Finally, "in" because it was a common ending for drugs at the time.</p>
<div class="thumb tleft">
<div class="thumbinner" style="width:252px;"><a href="../../../a/s/p/Image%7EAspirin.jpg_093d.html" class="internal" title="Aspirin"><img src="../../../upload/shared/thumb/7/7d/Aspirin.jpg/250px-Aspirin.jpg" alt="Aspirin" width="250" height="169" longdesc="../../../a/s/p/Image%7EAspirin.jpg_093d.html" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a href="../../../a/s/p/Image%7EAspirin.jpg_093d.html" class="internal" title="Enlarge"><img src="../../../skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Aspirin</div>
</div>
</div>
<p>On <a href="../../../m/a/r/March_6.html" title="March 6">March 6</a>, <a href="../../../1/8/9/1899.html" title="1899">1899</a>, <a href="../../../b/a/y/Bayer.html" title="Bayer">Bayer</a> registered it as a <a href="../../../t/r/a/Trademark.html" title="Trademark">trademark</a>. However, the German company lost the right to use the trademark in many countries because the <a href="../../../a/l/l/Allies.html" title="Allies">Allies</a> seized and resold its foreign assets after <a href="../../../w/o/r/World_War_I_9429.html" title="World War I">World War I</a>. The right to use "Aspirin" in the United States (along with all other Bayer trademarks) was purchased from the U.S. government by <a href="../../../s/t/e/Sterling_Drug_6edc.html" title="Sterling Drug">Sterling Drug</a> in 1918. Even before the <a href="../../../p/a/t/Patent.html" title="Patent">patent</a> for the drug expired in 1917, Bayer had been unable to stop competitors from copying the formula and using the name elsewhere, so, with a flooded market, the public was unable to recognize "Aspirin" as coming from only one manufacturer. Sterling was subsequently unable to prevent "Aspirin" from being ruled a <a href="../../../g/e/n/Genericized_trademark.html" title="Genericized trademark">genericized trademark</a> in a U.S. federal court in 1921. Sterling was ultimately acquired by Bayer in 1994, but this did not restore the U.S. trademark. Other countries (such as <a href="../../../c/a/n/Canada.html" title="Canada">Canada</a> and many countries in Europe) still consider "Aspirin" a protected trademark.</p>
<p><a name="Discovery" id="Discovery"></a></p>
<h2><span class="editsection">[<a href="../../../a/s/p/Aspirin.html" title="Edit section: Discovery">edit</a>]</span> <span class="mw-headline">Discovery</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:252px;"><a href="../../../a/c/e/Image%7EAcetylsalicylicacid.jpg_a08e.html" class="internal" title="Acetylsalicylic acid crystals"><img src="../../../upload/thumb/4/4c/Acetylsalicylicacid.jpg/250px-Acetylsalicylicacid.jpg" alt="Acetylsalicylic acid crystals" width="250" height="208" longdesc="../../../a/c/e/Image%7EAcetylsalicylicacid.jpg_a08e.html" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a href="../../../a/c/e/Image%7EAcetylsalicylicacid.jpg_a08e.html" class="internal" title="Enlarge"><img src="../../../skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Acetylsalicylic acid crystals</div>
</div>
</div>
<p><a href="../../../h/i/p/Hippocrates.html" title="Hippocrates">Hippocrates</a>, a <a href="../../../h/e/l/Hellenic_civilization.html" title="Hellenic civilization">Greek</a> physician, wrote in the 5th century BC about a bitter powder extracted from <a href="../../../w/i/l/Willow.html" title="Willow">willow</a> bark that could ease aches and pains and reduce fevers. This remedy is also mentioned in texts from ancient <a href="../../../s/u/m/Sumer.html" title="Sumer">Sumer</a>, <a href="../../../l/e/b/Lebanon.html" title="Lebanon">Lebanon</a>, and <a href="../../../a/s/s/Assyria.html" title="Assyria">Assyria</a>. The Cherokee and other Native Americans used an infusion of the bark for fever and other medicinal purposes for centuries.<sup id="_ref-0" class="reference"><a href="#_note-0" title="">[2]</a></sup> The medicinal part of the plant is the inner bark and was used as a pain reliever for a variety of ailments. The Reverend Edward Stone, a vicar from <a href="../../../c/h/i/Chipping_Norton%2C_Oxfordshire_5e77.html" title="Chipping Norton, Oxfordshire">Chipping Norton, Oxfordshire</a>, <a href="../../../e/n/g/England.html" title="England">England</a>, noted in 1763 that the bark of the willow was effective in reducing a fever.<sup id="_ref-RoyalSoc1763EdmundStone_0" class="reference"><a href="#_note-RoyalSoc1763EdmundStone" title="">[3]</a></sup></p>
<p>The active extract of the bark, called <i><a href="../../../s/a/l/Salicin.html" title="Salicin">salicin</a></i>, after the <a href="../../../l/a/t/Latin.html" title="Latin">Latin</a> name for the white willow (<i><a href="../../../s/a/l/Salix_alba.html" title="Salix alba">Salix alba</a></i>), was isolated to its crystalline form in 1828 by Henri Leroux, a <a href="../../../f/r/a/France.html" title="France">French</a> pharmacist, and Raffaele Piria, an <a href="../../../i/t/a/Italy.html" title="Italy">Italian</a> chemist. Piria was able to convert the substance into a sugar and a second component, which, on oxidation becomes <a href="../../../s/a/l/Salicylic_acid.html" title="Salicylic acid">salicylic acid</a>.</p>
<p>Salicylic acid was also isolated from the herb <a href="../../../m/e/a/Meadowsweet.html" title="Meadowsweet">meadowsweet</a> (<i><a href="../../../f/i/l/Filipendula.html" title="Filipendula">Filipendula ulmaria</a></i>, formerly classified as <i><a href="../../../s/p/i/Spiraea.html" title="Spiraea">Spiraea ulmaria</a></i>) by German researchers in 1839. While their extract was somewhat effective, it also caused digestive problems such as <a href="../../../g/a/s/Gastric.html" title="Gastric">gastric</a> irritation and bleeding and diarrhea, and even death when consumed in high doses. In 1853, a French chemist named <a href="../../../c/h/a/Charles_Frederic_Gerhardt_ca73.html" title="Charles Frederic Gerhardt">Charles Frederic Gerhardt</a> neutralized salicylic acid by buffering it with sodium (sodium salicylate) and <a href="../../../a/c/e/Acetyl_chloride.html" title="Acetyl chloride">acetyl chloride</a>, creating acetosalicylic anhydride. Gerhardt's product worked, but he had no desire to market it and abandoned his discovery. In 1897, researcher Arthur Eichengrün and <a href="../../../f/e/l/Felix_Hoffmann_d592.html" title="Felix Hoffmann">Felix Hoffmann</a>, a research assistant at <a href="../../../b/a/y/Bayer.html" title="Bayer">Friedrich Bayer &amp; Co.</a> in <a href="../../../g/e/r/Germany.html" title="Germany">Germany</a>, derived one of the <a href="../../../h/y/d/Hydroxy.html" title="Hydroxy">hydroxyl</a> <a href="../../../f/u/n/Functional_group.html" title="Functional group">functional groups</a> in salicylic acid with an <a href="../../../a/c/e/Acetyl.html" title="Acetyl">acetyl</a> group (forming acetylsalicylic acid, an acetyl <a href="../../../e/s/t/Ester.html" title="Ester">ester</a>). This thereby greatly reduced the negative effects caused by the free phenolic group of salicylic acid. When in the body, the ester (aspirin) is hydrolyzed to free the active drug. This was the first synthetic drug, not a copy of something that existed in nature, and the start of the pharmaceuticals industry.</p>
<p>Hoffmann made some of the formula and gave it to his father, who was suffering from the pain of arthritis and could not stand the side effects of salicylic acid. With good results, he then convinced <a href="../../../b/a/y/Bayer.html" title="Bayer">Bayer</a> to market the new wonder drug. 'Aspirin' was <a href="../../../p/a/t/Patent.html" title="Patent">patented</a> on March 6, 1899. It was marketed alongside another of Hoffmann's products, an acetylated synthetic of <a href="../../../m/o/r/Morphine.html" title="Morphine">morphine</a> called '<a href="../../../h/e/r/Heroin.html" title="Heroin">Heroin</a>' that he invented 11 days after aspirin. Heroin was initially the more successful of the two painkillers and it was common belief that it was healthier than aspirin. But, as heroin's shortcoming of addictiveness became more obvious, aspirin stepped to the forefront. Aspirin was originally sold as a powder (still the preferred form in many European countries) and was an instant success; in 1915, Bayer introduced aspirin tablets.</p>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="../../../b/a/y/Image%7EBayerHeroin.png_3b0d.html" class="internal" title="Advertisement for Asprin, Heroin, Lycetol, Salophen"><img src="../../../upload/thumb/7/79/BayerHeroin.png/180px-BayerHeroin.png" alt="Advertisement for Asprin, Heroin, Lycetol, Salophen" width="180" height="240" longdesc="../../../b/a/y/Image%7EBayerHeroin.png_3b0d.html" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a href="../../../b/a/y/Image%7EBayerHeroin.png_3b0d.html" class="internal" title="Enlarge"><img src="../../../skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Advertisement for Asprin, Heroin, Lycetol, Salophen</div>
</div>
</div>
<p>Several claims to invention of acetylsalicylic acid have arisen. Acetylsalicylic acid was already being manufactured by the Chemische Fabrik von Heyden Company in 1897, although without a brand name. <a href="../../../a/r/t/Arthur_Eichengr%C3%BCn_09be.html" title="Arthur Eichengrün">Arthur Eichengrün</a> claimed in 1949 that he planned and directed the synthesis of aspirin while Hoffmann's role was restricted to the initial lab synthesis using Eichengrün's process. In 1999, Walter Sneader of the Department of Pharmaceutical Sciences at the <a href="../../../u/n/i/University_of_Strathclyde_d765.html" title="University of Strathclyde">University of Strathclyde</a> in <a href="../../../g/l/a/Glasgow.html" title="Glasgow">Glasgow</a> reexamined the case and agreed with Eichengrün's account. Bayer continues to recognize Felix Hoffmann as aspirin's official inventor. Despite its argued origin, Bayer's marketing was responsible for bringing it to the world.</p>
<p>It was not until the 1970s that the mechanism of action of aspirin and similar drugs called <a href="../../../n/s/a/NSAID_a6d3.html" title="NSAID">NSAIDs</a> was elucidated (see below).</p>
<p><a name="Synthesis_of_aspirin" id="Synthesis_of_aspirin"></a></p>
<h2><span class="editsection">[<a href="../../../a/s/p/Aspirin.html" title="Edit section: Synthesis of aspirin">edit</a>]</span> <span class="mw-headline">Synthesis of aspirin</span></h2>
<p>Aspirin is commercially synthesized using a two-step process. First, <a href="../../../p/h/e/Phenol.html" title="Phenol">phenol</a> (generally extracted from coal tar) is treated with a sodium base which generates sodium phenoxide, which is then reacted with <a href="../../../c/a/r/Carbon_dioxide.html" title="Carbon dioxide">carbon dioxide</a> under high temperature and pressure to yield <a href="../../../s/a/l/Salicylate.html" title="Salicylate">salicylate</a>, which is acidified, yielding <a href="../../../s/a/l/Salicylic_acid.html" title="Salicylic acid">salicylic acid</a>. This process is known as the <a href="../../../k/o/l/Kolbe-Schmitt_reaction_80e6.html" title="Kolbe-Schmitt reaction">Kolbe-Schmitt reaction</a>.</p>
<dl>
<dd><a href="../../../k/o/l/Image%7EKolbe-Schmitt.png_3d2e.html" class="image" title=""><img src="../../../upload/thumb/a/ac/Kolbe-Schmitt.png/400px-Kolbe-Schmitt.png" alt="" width="400" height="81" longdesc="../../../k/o/l/Image%7EKolbe-Schmitt.png_3d2e.html" /></a></dd>
</dl>
<p>Salicylic acid is then <a href="../../../a/c/e/Acetylation.html" title="Acetylation">acetylated</a> using <a href="../../../a/c/e/Acetic_anhydride.html" title="Acetic anhydride">acetic anhydride</a>, yielding aspirin and <a href="../../../a/c/e/Acetic_acid.html" title="Acetic acid">acetic acid</a> as a byproduct. It is a common experiment performed in undergraduate organic chemistry practicals, and generally tends to produce low yields due to the relative difficulty of its extraction from an aqueous state. The trick to getting the reaction to work is to acidify with <a href="../../../p/h/o/Phosphoric_acid.html" title="Phosphoric acid">phosphoric acid</a> and heat the reagents under reflux with a boiling water bath for between 40 to 60 minutes.</p>
<p>The original synthesis of aspirin from salicylic acid involved acetylation with <a href="../../../a/c/e/Acetyl_chloride.html" title="Acetyl chloride">acetyl chloride</a>. Unfortunately, the byproduct from this is <a href="../../../h/y/d/Hydrochloric_acid.html" title="Hydrochloric acid">hydrochloric acid</a>, which is corrosive and environmentally hazardous. As described above, it was then later found that acetic anhydride was a better acylating agent, with the byproduct acetic acid formed, which does not have the unwanted properties of hydrochloric acid and can also be recycled.</p>
<dl>
<dd><a href="../../../a/s/p/Image%7EAspirin_synthesis.png_bcfd.html" class="image" title=""><img src="../../../upload/thumb/e/ef/Aspirin_synthesis.png/490px-Aspirin_synthesis.png" alt="" width="490" height="82" longdesc="../../../a/s/p/Image%7EAspirin_synthesis.png_bcfd.html" /></a></dd>
</dl>
<p>Formulations containing high concentrations of aspirin often smell like <a href="../../../v/i/n/Vinegar.html" title="Vinegar">vinegar</a>. This is because aspirin can undergo <a href="../../../a/u/t/Autocatalytic.html" title="Autocatalytic">autocatalytic</a> degradation to salicylic acid in moist conditions, yielding salicylic acid and <a href="../../../a/c/e/Acetic_acid.html" title="Acetic acid">acetic acid</a>.</p>
<p>The acid dissociation constant (<a href="../../../a/c/i/Acid_dissociation_constant.html" title="Acid dissociation constant">pK<sub>a</sub></a>) for Acetylsalicylic acid is 3.5 at 25&#160;°C.<sup id="_ref-asaaciddissconst_0" class="reference"><a href="#_note-asaaciddissconst" title="">[4]</a></sup> ASA, being a weak acid, dissociates as shown by the following reaction equation:</p>
<dl>
<dd><a href="../../../a/s/a/Image%7EAsa_acid_dissociation_342.jpg_2000.html" class="image" title=""><img src="../../../upload/shared/0/04/Asa_acid_dissociation_342.jpg" alt="" width="417" height="103" longdesc="../../../a/s/a/Image%7EAsa_acid_dissociation_342.jpg_2000.html" /></a></dd>
</dl>
<p><a name="Mechanism_of_action" id="Mechanism_of_action"></a></p>
<h2><span class="editsection">[<a href="../../../a/s/p/Aspirin.html" title="Edit section: Mechanism of action">edit</a>]</span> <span class="mw-headline">Mechanism of action</span></h2>
<p>In <a href="../../../1/9/7/1971.html" title="1971">1971</a>, the British pharmacologist, <a href="../../../j/o/h/John_Robert_Vane_6dfc.html" title="John Robert Vane">John Robert Vane</a>, who was then employed by the Royal College of Surgeons in London, showed that aspirin had suppressed the production of <a href="../../../p/r/o/Prostaglandins.html" title="Prostaglandins">prostaglandins</a> and <a href="../../../t/h/r/Thromboxanes.html" title="Thromboxanes">thromboxanes</a>.<sup id="_ref-1" class="reference"><a href="#_note-1" title="">[5]</a></sup> For this piece of research he was awarded both a <a href="../../../n/o/b/Nobel_Prize_c061.html" title="Nobel Prize">Nobel Prize</a> in <a href="../../../n/o/b/Nobel_Prize_in_Physiology_or_Medicine_b5e4.html" title="Nobel Prize in Physiology or Medicine">Physiology or Medicine</a> in <a href="../../../1/9/8/1982.html" title="1982">1982</a> and a knighthood.</p>
<p>Aspirin's ability to suppress the production of prostaglandins and thromboxanes is due to its non-competitive and irreversible inhibition of the <a href="../../../c/y/c/Cyclooxygenase.html" title="Cyclooxygenase">cyclooxygenase</a> (COX) enzyme. Cyclooxygenase is required for prostaglandin and thromboxane synthesis. Aspirin acts as an acetylating agent where an acetyl group is covalently attached to a serine residue in the active site of the COX enzyme. This makes aspirin different from other NSAIDs (such as <a href="../../../d/i/c/Diclofenac.html" title="Diclofenac">diclofenac</a> and <a href="../../../i/b/u/Ibuprofen.html" title="Ibuprofen">ibuprofen</a>), which are reversible inhibitors.</p>
<p>Prostaglandins are local <a href="../../../h/o/r/Hormone.html" title="Hormone">hormones</a> (paracrine) produced in the body and have diverse effects in the body, including but not limited to transmission of pain information to the brain, modulation of the <a href="../../../h/y/p/Hypothalamus.html" title="Hypothalamus">hypothalamic</a> thermostat, and inflammation. Thromboxanes are responsible for the aggregation of <a href="../../../p/l/a/Platelet.html" title="Platelet">platelets</a> that form <a href="../../../c/l/o/Clot.html" title="Clot">blood clots</a>. Heart attacks are primarily caused by blood clots, and their reduction with the introduction of small amounts of aspirin has been seen to be an effective medical intervention. The side-effect of this is that the ability of the blood in general to clot is reduced, and excessive bleeding may result from the use of aspirin.</p>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="../../../a/s/p/Image%7EAspirin-rod-povray.png_3809.html" class="internal" title="3D model of chemical structure of aspirin"><img src="../../../upload/shared/thumb/4/40/Aspirin-rod-povray.png/180px-Aspirin-rod-povray.png" alt="3D model of chemical structure of aspirin" width="180" height="135" longdesc="../../../a/s/p/Image%7EAspirin-rod-povray.png_3809.html" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a href="../../../a/s/p/Image%7EAspirin-rod-povray.png_3809.html" class="internal" title="Enlarge"><img src="../../../skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
3D model of chemical structure of aspirin</div>
</div>
</div>
<p>There are at least two different types of cyclooxygenase: COX-1 and COX-2. Aspirin irreversibly inhibits COX-1 and modifies the enzymatic activity of COX-2. Normally COX-2 produces prostanoids, most of which are pro-inflammatory. Aspirin-modified COX-2 produces lipoxins, most of which are anti-inflammatory. Newer NSAID drugs called <a href="../../../c/o/x/COX-2_selective_inhibitor_6b7f.html" title="COX-2 selective inhibitor">COX-2 selective inhibitors</a> have been developed that inhibit only COX-2, with the hope for reduction of gastrointestinal side-effects.</p>
<p>However, several of the new <a href="../../../c/o/x/COX-2_selective_inhibitor_6b7f.html" title="COX-2 selective inhibitor">COX-2 selective inhibitors</a> have been recently withdrawn, after evidence emerged that COX-2 inhibitors increase the risk of heart attack. It is proposed that endothelial cells lining the microvasculature in the body express COX-2, and, by selectively inhibiting COX-2, prostaglandins (specifically PGI2; prostacyclin) are downregulated with respect to thromboxane levels, as COX-1 in platelets is unaffected. Thus, the protective anti-coagulative effect of PGI2 is decreased, increasing the risk of thrombus and associated heart attacks and other circulatory problems. Since platelets have no DNA, they are unable to synthesize new COX once aspirin has irreversibly inhibited the enzyme, an important difference with reversible inhibitors.</p>
<p>Furthermore, aspirin has 2 additional modes of actions, contributing to its strong analgesic, antipyretic and anti-inflammatory properties:</p>
<ul>
<li>It uncouples oxidative phosphorylation in cartilaginous (and hepatic) mitochondria, by diffusing from the inner membrane space as a proton carrier back into the mitochondrial matrix, where it ionizes once again to release protons. In short, aspirin buffers and transports the protons. (Note: This effect in high doses of aspirin actually causes fever due to the heat released from the electron transport chain, instead of its normal antipyretic action.</li>
<li>It induces the formation of NO-radicals in the body that enable the white blood cells (leukocytes) to fight infections more effectively. This has been found recently by Dr. Derek W. Gilroy, winning Bayer's International Aspirin Award 2005.<sup id="_ref-2" class="reference"><a href="#_note-2" title="">[6]</a></sup></li>
</ul>
<p>More recent data suggest that salicylic acid and its derivatives will modulate NFκB signaling.<sup class="noprint Template-Fact"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since February 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup> NFκB is a transcription factor complex that plays a central role in many biological processes, including inflammation.</p>
<p><a name="Indications" id="Indications"></a></p>
<h2><span class="editsection">[<a href="../../../a/s/p/Aspirin.html" title="Edit section: Indications">edit</a>]</span> <span class="mw-headline">Indications</span></h2>
<p>Aspirin, as with many older drugs, has proven to be useful in many conditions. Despite its well-known toxicity it is widely used, since physicians are familiar with its properties. Indications for its use include:</p>
<ul>
<li><a href="../../../f/e/v/Fever.html" title="Fever">Fever</a></li>
<li><a href="../../../p/a/i/Pain_and_nociception.html" title="Pain and nociception">Pain</a> (especially useful for some forms of <a href="../../../a/r/t/Arthritis.html" title="Arthritis">arthritis</a>, osteoid <a href="../../../o/s/t/Osteoma.html" title="Osteoma">osteoma</a>, and chronic pain)</li>
<li><a href="../../../m/i/g/Migraine.html" title="Migraine">Migraine</a></li>
<li><a href="../../../r/h/e/Rheumatic_fever.html" title="Rheumatic fever">Rheumatic fever</a> (drug of choice)</li>
<li><a href="../../../k/a/w/Kawasaki_disease.html" title="Kawasaki disease">Kawasaki disease</a> (along with IVIG)</li>
<li><a href="../../../p/e/r/Pericarditis.html" title="Pericarditis">Pericarditis</a></li>
<li><a href="../../../c/o/r/Coronary_artery_disease.html" title="Coronary artery disease">Coronary artery disease</a></li>
<li>Acute <a href="../../../m/y/o/Myocardial_infarction.html" title="Myocardial infarction">myocardial infarction</a><sup id="_ref-Lancet1988-ISIS2_0" class="reference"><a href="#_note-Lancet1988-ISIS2" title="">[7]</a></sup></li>
</ul>
<p>In addition, aspirin is recommended (low dose, 75-81 mg daily) for the prevention of:</p>
<ul>
<li>Myocardial infarction — in patients with either documented coronary artery disease or at elevated risk of <a href="../../../c/a/r/Cardiovascular_disease.html" title="Cardiovascular disease">cardiovascular disease</a></li>
<li><a href="../../../s/t/r/Stroke.html" title="Stroke">Stroke</a> — as <a href="../../../s/e/c/Secondary_prevention.html" title="Secondary prevention">secondary prevention</a> (i.e. to prevent recurrence)</li>
</ul>
<p><a name="Dosage" id="Dosage"></a></p>
<h3><span class="editsection">[<a href="../../../a/s/p/Aspirin.html" title="Edit section: Dosage">edit</a>]</span> <span class="mw-headline">Dosage</span></h3>
<p>For adults doses of 300 to 1000 mg are generally taken four times a day for fever or arthritis, with a maximum dose of 8000 mg a day.<sup id="_ref-3" class="reference"><a href="#_note-3" title="">[8]</a></sup> The correct dose of aspirin depends on the disease process that is being treated. For instance, for the treatment of rheumatic fever, doses near the maximal daily dose have been used historically. For the prevention of myocardial infarction in someone with documented or suspected coronary artery disease, doses as low as 75 mg daily (or possibly even lower) are sufficient.</p>
<p>For those under 12 years of age, the dose previously varied with the age, but aspirin is no longer routinely used in children due to the association with <a href="../../../r/e/y/Reye%27s_syndrome.html" title="Reye's syndrome">Reye's syndrome</a>; <a href="../../../p/a/r/Paracetamol.html" title="Paracetamol">paracetamol</a> or other NSAIDs, such as <a href="../../../i/b/u/Ibuprofen.html" title="Ibuprofen">Ibuprofen</a>, are now being used instead. <a href="../../../k/a/w/Kawasaki_disease.html" title="Kawasaki disease">Kawasaki disease</a> remains one of the few indications for aspirin use in children with aspirin initially started at 7.5-12.5 mg/kg body weight taken four times a day for up to two weeks and then continued at 5 mg/kg once daily for a further six to eight weeks.<sup id="_ref-4" class="reference"><a href="#_note-4" title="">[9]</a></sup></p>
<p><a name="Toxicity_of_low-dose_aspirin" id="Toxicity_of_low-dose_aspirin"></a></p>
<h2><span class="editsection">[<a href="../../../a/s/p/Aspirin.html" title="Edit section: Toxicity of low-dose aspirin">edit</a>]</span> <span class="mw-headline">Toxicity of low-dose aspirin</span></h2>
<p>A recent review states: "....low-dose aspirin increases the risk of major bleeding 2-fold compared with placebo. However, the annual incidence of major bleeding due to low-dose aspirin is modest—only 1.3 patients per thousand higher than what is observed with placebo treatment. Treatment of approximately 800 patients with low-dose aspirin annually for cardiovascular prophylaxis will result in only 1 additional major bleeding episode." Further, "...the cost to prevent one major GI bleeding episode from aspirin in 1 year by substituting clopidogrel therapy would be $1,216,180..."<sup id="_ref-AmJMed2006-ASAClopidogrelReviewArticle_0" class="reference"><a href="#_note-AmJMed2006-ASAClopidogrelReviewArticle" title="">[10]</a></sup></p>
<p><a name="Contraindications_and_warnings" id="Contraindications_and_warnings"></a></p>
<h2><span class="editsection">[<a href="../../../a/s/p/Aspirin.html" title="Edit section: Contraindications and warnings">edit</a>]</span> <span class="mw-headline">Contraindications and warnings</span></h2>
<ul>
<li>Aspirin should be avoided by those known to be allergic to <a href="../../../i/b/u/Ibuprofen.html" title="Ibuprofen">ibuprofen</a> or <a href="../../../n/a/p/Naproxen.html" title="Naproxen">naproxen</a>.</li>
<li>Caution should be exercised in those with <a href="../../../a/s/t/Asthma.html" title="Asthma">asthma</a> or <a href="../../../n/s/a/NSAID_a6d3.html" title="NSAID">NSAID</a>-precipitated <a href="../../../b/r/o/Bronchospasm.html" title="Bronchospasm">bronchospasm</a>.</li>
<li>It is generally recommended that one seek medical help if symptoms do not improve after a few days of therapy.</li>
<li>Caution should be taken in patients with <a href="../../../k/i/d/Kidney_disease.html" title="Kidney disease">kidney disease</a>, <a href="../../../p/e/p/Peptic_ulcer.html" title="Peptic ulcer">peptic ulcers</a>, mild <a href="../../../d/i/a/Diabetes.html" title="Diabetes">diabetes</a>, <a href="../../../g/o/u/Gout.html" title="Gout">gout</a> or <a href="../../../g/a/s/Gastritis.html" title="Gastritis">gastritis</a>; manufacturers recommend talking to one's doctor before using this medicine.</li>
<li>Taking aspirin with <a href="../../../a/l/c/Alcoholic_beverage.html" title="Alcoholic beverage">alcohol</a> increases the chance of <a href="../../../g/a/s/Gastrointestinal_hemorrhage.html" title="Gastrointestinal hemorrhage">gastrointestinal hemorrhage</a> (stomach bleeding).</li>
<li>Children, including teenagers, are discouraged from using aspirin in cold or flu symptoms as this has been linked with <a href="../../../r/e/y/Reye%27s_syndrome.html" title="Reye's syndrome">Reye's syndrome</a>.<sup id="_ref-BMJ2002-Macdonald_1" class="reference"><a href="#_note-BMJ2002-Macdonald" title="">[1]</a></sup></li>
<li>Patients with <a href="../../../h/e/m/Hemophilia.html" title="Hemophilia">hemophilia</a> or other bleeding tendencies should not take salicylates.</li>
<li>Some sources recommend that patients with <a href="../../../h/y/p/Hyperthyroidism.html" title="Hyperthyroidism">hyperthyroidism</a> avoid aspirin because it elevates T4 levels. <a href="http://www.patient.co.uk/showdoc/40001339/" class="external autonumber" title="http://www.patient.co.uk/showdoc/40001339/" rel="nofollow">[2]</a></li>
</ul>
<p><a name="Common_side-effects" id="Common_side-effects"></a></p>
<h2><span class="editsection">[<a href="../../../a/s/p/Aspirin.html" title="Edit section: Common side-effects">edit</a>]</span> <span class="mw-headline">Common side-effects</span></h2>
<ul>
<li>Gastrointestinal complaints (stomach upset, <a href="../../../d/y/s/Dyspepsia.html" title="Dyspepsia">dyspepsia</a>, heartburn, small blood loss). To help avoid these problems, it is recommended that aspirin be taken at or after meals. Undetected blood loss may lead to <a href="../../../h/y/p/Hypochromic_anemia.html" title="Hypochromic anemia">hypochromic anemia</a>.</li>
<li>Severe gastrointestinal complaints (gross bleeding and/or ulceration), requiring discontinuation and immediate treatment. Patients receiving high doses and/or long-term treatment should receive gastric protection with high-dosed antacids, <a href="../../../r/a/n/Ranitidine.html" title="Ranitidine">ranitidine</a> or <a href="../../../o/m/e/Omeprazole.html" title="Omeprazole">omeprazole</a>.</li>
<li>Frequently, central effects (dizziness, <a href="../../../t/i/n/Tinnitus.html" title="Tinnitus">tinnitus</a>, hearing loss, <a href="../../../v/e/r/Vertigo_%28medical%29.html" title="Vertigo (medical)">vertigo</a>, centrally mediated vision disturbances, and headaches). The higher the daily dose is, the more likely it is that central nervous system side effects will occur.</li>
<li>Sweating, seen with high doses, independent from antipyretic action</li>
<li>Long-term treatment with high doses (arthritis and rheumatic fever): often increased liver enzymes without symptoms, rarely reversible liver damage. The potentially fatal <a href="../../../r/e/y/Reye%27s_syndrome.html" title="Reye's syndrome">Reye's syndrome</a> may occur, if given to pediatric patients with fever and other signs of infections. The syndrome is due to fatty degeneration of liver cells. Up to 30 percent of those afflicted will eventually die. Prompt hospital treatment may be life-saving.</li>
<li>Chronic <a href="../../../n/e/p/Nephritis.html" title="Nephritis">nephritis</a> with long-term use, usually if used in combination with certain other painkillers. This condition may lead to chronic renal failure.</li>
<li>Prolonged and more severe bleeding after operations and post-traumatic for up to 10 days after the last aspirin dose. If one wishes to counteract the bleeding tendency, fresh <a href="../../../t/h/r/Thrombocyte.html" title="Thrombocyte">thrombocyte</a> concentrate will usually work.</li>
<li>Skin reactions, <a href="../../../a/n/g/Angioedema.html" title="Angioedema">angioedema</a>, and <a href="../../../b/r/o/Bronchospasm.html" title="Bronchospasm">bronchospasm</a> have all been seen infrequently.</li>
<li>Patients that have the genetic disease known as Glucose-6-Phosphate Dehydrogenase deficiency (G6PD) should avoid this drug as it is known to cause hemolytic anemia in large doses depending on the severity of the disease.</li>
</ul>
<p><a name="Interactions" id="Interactions"></a></p>
<h2><span class="editsection">[<a href="../../../a/s/p/Aspirin.html" title="Edit section: Interactions">edit</a>]</span> <span class="mw-headline">Interactions</span></h2>
<p>Aspirin can <a href="../../../d/r/u/Drug_interaction.html" title="Drug interaction">interact</a> with some other drugs. Some drugs, for example those used for <a href="../../../d/i/a/Diabetes.html" title="Diabetes">diabetes</a>, are bound by <a href="../../../p/l/a/Plasma_protein.html" title="Plasma protein">plasma protein</a> in the blood supply and are therefore not free to react with their targets. However, aspirin may displace them from plasma protein, leading to a drug <a href="../../../o/v/e/Overdose.html" title="Overdose">overdose</a>. Aspirin has this same effect on <a href="../../../a/n/t/Anticoagulants.html" title="Anticoagulants">anticoagulants</a>.</p>
<p><a name="Overdose" id="Overdose"></a></p>
<h2><span class="editsection">[<a href="../../../a/s/p/Aspirin.html" title="Edit section: Overdose">edit</a>]</span> <span class="mw-headline">Overdose</span></h2>
<p>Aspirin overdose can be acute or chronic. In acute poisoning, a single large dose is taken; in chronic poisoning, supratherapeutic doses are taken over a period of time. Acute overdose has a <a href="../../../m/o/r/Mortality_rate.html" title="Mortality rate">mortality rate</a> of 2%. Chronic overdose is more commonly lethal with a mortality rate of 25%; chronic overdose may be especially severe in children.<sup id="_ref-Pediatrics1982-gaudreault_0" class="reference"><a href="#_note-Pediatrics1982-gaudreault" title="">[11]</a></sup></p>
<p><a name="Symptoms" id="Symptoms"></a></p>
<h3><span class="editsection">[<a href="../../../a/s/p/Aspirin.html" title="Edit section: Symptoms">edit</a>]</span> <span class="mw-headline">Symptoms</span></h3>
<p>Aspirin overdose has potentially serious consequences, sometimes leading to significant morbidity and mortality. Patients with mild intoxication frequently have <a href="../../../n/a/u/Nausea.html" title="Nausea">nausea</a> and <a href="../../../v/o/m/Vomiting.html" title="Vomiting">vomiting</a>, abdominal pain, lethargy, <a href="../../../t/i/n/Tinnitus.html" title="Tinnitus">tinnitus</a>, and <a href="../../../d/i/z/Dizziness.html" title="Dizziness">dizziness</a>. More significant symptoms occur in more severe poisonings and include <a href="../../../h/y/p/Hyperthermia.html" title="Hyperthermia">hyperthermia</a>, <a href="../../../t/a/c/Tachypnea.html" title="Tachypnea">tachypnea</a>, <a href="../../../r/e/s/Respiratory_alkalosis.html" title="Respiratory alkalosis">respiratory alkalosis</a>, <a href="../../../m/e/t/Metabolic_acidosis.html" title="Metabolic acidosis">metabolic acidosis</a>, <a href="../../../h/y/p/Hypokalemia.html" title="Hypokalemia">hypokalemia</a>, <a href="../../../h/y/p/Hypoglycemia.html" title="Hypoglycemia">hypoglycemia</a>, <a href="../../../h/a/l/Hallucinations.html" title="Hallucinations">hallucinations</a>, <a href="../../../m/e/n/Mental_confusion.html" title="Mental confusion">confusion</a>, <a href="../../../s/e/i/Seizure.html" title="Seizure">seizure</a>, <a href="../../../c/e/r/Cerebral_edema.html" title="Cerebral edema">cerebral edema</a>, and <a href="../../../c/o/m/Coma.html" title="Coma">coma</a>. The most common cause of <a href="../../../d/e/a/Death.html" title="Death">death</a> following an aspirin overdose is cardiopulmonary arrest usually due to <a href="../../../p/u/l/Pulmonary_edema.html" title="Pulmonary edema">pulmonary edema</a>.<sup id="_ref-ActaAnaesthesiol1987-Thisted_0" class="reference"><a href="#_note-ActaAnaesthesiol1987-Thisted" title="">[12]</a></sup></p>
<p><a name="Toxicity" id="Toxicity"></a></p>
<h3><span class="editsection">[<a href="../../../a/s/p/Aspirin.html" title="Edit section: Toxicity">edit</a>]</span> <span class="mw-headline">Toxicity</span></h3>
<p>The <a href="../../../t/o/x/Toxic.html" title="Toxic">toxic</a> dose of aspirin is generally considered greater than 150 mg per kg of body mass. Moderate toxicity occurs at doses up to 300 mg/kg, severe toxicity occurs between 300 to 500 mg/kg, and a potentially lethal dose is greater than 500 mg/kg.<sup id="_ref-ArchInternMed1981-Temple_0" class="reference"><a href="#_note-ArchInternMed1981-Temple" title="">[13]</a></sup> This is the equivalent of many dozens of the common 325 mg tablets, depending on body weight. Note that children cannot tolerate as much aspirin per unit body weight as adults can, even when aspirin is indicated. Label-directions should be followed carefully.</p>
<p><a name="Treatment" id="Treatment"></a></p>
<h3><span class="editsection">[<a href="../../../a/s/p/Aspirin.html" title="Edit section: Treatment">edit</a>]</span> <span class="mw-headline">Treatment</span></h3>
<p>All overdose patients must be taken to a hospital immediately.</p>
<p>Initial treatment of an acute overdose includes gastric decontamination of the patient. This is achieved by administering <a href="../../../a/c/t/Activated_charcoal.html" title="Activated charcoal">activated charcoal</a> which <a href="../../../a/d/s/Adsorbs.html" title="Adsorbs">adsorbs</a> the aspirin in the <a href="../../../g/a/s/Gastrointestinal_tract.html" title="Gastrointestinal tract">gastrointestinal tract</a>. <a href="../../../g/a/s/Gastric_lavage.html" title="Gastric lavage">Stomach pumps</a> are no longer routinely used in the treatment of poisonings but are sometimes considered if the patient has ingested a potentially lethal amount up to 1 hour previously.<sup id="_ref-5" class="reference"><a href="#_note-5" title="">[14]</a></sup> Repeated doses of charcoal have been proposed to be beneficial in aspirin overdose.<sup id="_ref-BMJ1985-hillman_0" class="reference"><a href="#_note-BMJ1985-hillman" title="">[15]</a></sup> A study performed found that repeat dose charcoal might not be of significant value.<sup id="_ref-ArchInternMed1990-Kirshenbaum_0" class="reference"><a href="#_note-ArchInternMed1990-Kirshenbaum" title="">[16]</a></sup> However, most toxicologists will administer additional charcoal if serum salicylate levels are increasing.</p>
<p>Patients are monitored until their peak salicylate blood level has been determined.<sup id="_ref-EmergMed2002-Dargan_0" class="reference"><a href="#_note-EmergMed2002-Dargan" title="">[17]</a></sup> Blood levels are usually performed 4 hours after ingestion and then every 2 hours after that to determine the maximum level. Maximum levels can be used as a guide to toxic effects expected.<sup id="_ref-drugs1986-Meredith_0" class="reference"><a href="#_note-drugs1986-Meredith" title="">[18]</a></sup></p>
<p>There is no antidote to salicylate poisoning. Frequent blood work is performed to check <a href="../../../m/e/t/Metabolic.html" title="Metabolic">metabolic</a>, <a href="../../../s/a/l/Salicylate.html" title="Salicylate">salicylate</a>, and <a href="../../../b/l/o/Blood_sugar.html" title="Blood sugar">blood sugar</a> levels; <a href="../../../a/r/t/Arterial_blood_gas.html" title="Arterial blood gas">arterial blood gas</a> assessments are performed to test for <a href="../../../a/l/k/Alkalosis.html" title="Alkalosis">respiratory alkalosis</a> and <a href="../../../m/e/t/Metabolic_acidosis.html" title="Metabolic acidosis">metabolic acidosis</a>. Patients are monitored and often treated according to their individual symptoms, patients may be given <a href="../../../i/n/t/Intravenous.html" title="Intravenous">intravenous</a> <a href="../../../p/o/t/Potassium_chloride.html" title="Potassium chloride">potassium chloride</a> to counteract <a href="../../../h/y/p/Hypokalemia.html" title="Hypokalemia">hypokalemia</a>, <a href="../../../g/l/u/Glucose.html" title="Glucose">glucose</a> to restore <a href="../../../b/l/o/Blood_sugar.html" title="Blood sugar">blood sugar</a> levels, <a href="../../../b/e/n/Benzodiazepines.html" title="Benzodiazepines">benzodiazepines</a> for any seizure activity, fluids for <a href="../../../d/e/h/Dehydration.html" title="Dehydration">dehydration</a>, and importantly <a href="../../../s/o/d/Sodium_bicarbonate.html" title="Sodium bicarbonate">sodium bicarbonate</a> to restore the blood's sensitive <a href="../../../p/h/_/PH_a254.html" title="PH">pH</a> balance. Sodium bicarbonate also has the effect of increasing the pH of urine, which in turn increases the elimination of salicylate. Additionally, <a href="../../../h/e/m/Hemodialysis.html" title="Hemodialysis">hemodialysis</a> can be implemented to enhance the removal of salicylate from the blood. Hemodialysis is usually used in severely poisoned patients; for example, patients with significantly high salicylate blood levels, significant neurotoxicity (agitation, coma, convulsions), renal failure, pulmonary edema, or cardiovascular instability are hemodialyzed.<sup id="_ref-EmergMed2002-Dargan_1" class="reference"><a href="#_note-EmergMed2002-Dargan" title="">[17]</a></sup> Hemodialysis also has the advantage of restoring <a href="../../../e/l/e/Electrolyte.html" title="Electrolyte">electrolyte</a> and <a href="../../../a/c/i/Acid-base.html" title="Acid-base">acid-base</a> abnormalities; hemodialysis is often life-saving in severely ill patients.</p>
<p>If the overdose was intentional, the patient should undergo <a href="../../../p/s/y/Psychiatric.html" title="Psychiatric">psychiatric</a> evaluation, as with any <a href="../../../s/u/i/Suicide.html" title="Suicide">suicide</a> attempt.</p>
<p><a name="Epidemiology" id="Epidemiology"></a></p>
<h3><span class="editsection">[<a href="../../../a/s/p/Aspirin.html" title="Edit section: Epidemiology">edit</a>]</span> <span class="mw-headline">Epidemiology</span></h3>
<p>In the later part of the 20th century the number of salicylate poisonings has declined mainly due to the popularity of other over-the-counter analgesics such as <a href="../../../p/a/r/Paracetamol.html" title="Paracetamol">paracetamol</a>. Fifty-two deaths involving single-ingredient aspirin were reported in the <a href="../../../u/n/i/United_States_09d4.html" title="United States">United States</a> in the year 2000. However, in all but three cases, the reason for the ingestion of lethal doses was intentional, predominantly suicides.<sup id="_ref-AmJEmergMed2001-Litovitz_0" class="reference"><a href="#_note-AmJEmergMed2001-Litovitz" title="">[19]</a></sup></p>
<p><a name="Research_into_cancer_prevention" id="Research_into_cancer_prevention"></a></p>
<h2><span class="editsection">[<a href="../../../a/s/p/Aspirin.html" title="Edit section: Research into cancer prevention">edit</a>]</span> <span class="mw-headline">Research into cancer prevention</span></h2>
<p>The role that aspirin might have in reducing the rates of certain cancers has been the subject of many studies. However, given the side effects of NSAIDs on increased gastrointestinal bleeding and rates of heart disease, there is no current medical recommendation to use these drugs for cancer reduction.</p>
<ul>
<li><b>Prostate</b> - While there is some epidemiological information suggesting a correlation between the reduction of prostate cancer and aspirin use, two recent studies (a multicentric case-control study and epidemiological study) were inconclusive.<sup id="_ref-6" class="reference"><a href="#_note-6" title="">[20]</a></sup><sup id="_ref-7" class="reference"><a href="#_note-7" title="">[21]</a></sup></li>
</ul>
<ul>
<li><b>Colon</b> - A 2005 <a href="../../../j/o/u/Journal_of_the_American_Medical_Association_e204.html" title="Journal of the American Medical Association">JAMA</a> article states that aspirin may prevent carcinoma of the colon, when taken in at least twice-daily adult (325 mg) doses.<sup id="_ref-8" class="reference"><a href="#_note-8" title="">[22]</a></sup> It follows an earlier study, also using the <a href="../../../n/u/r/Nurses%27_Health_Study_49e4.html" title="Nurses' Health Study">Nurses' Health Study</a> (NHS) women, which had similar conclusions but with a smaller testing population.<sup id="_ref-9" class="reference"><a href="#_note-9" title="">[23]</a></sup> The conclusion of the JAMA study was that both aspirin and other non-aspirin NSAIDs used over a long time (best results seen after at least a decade of regular use) reduce risk of colorectal cancer. The risk was reduced the most at doses higher than 14 tablets per week (full-strength aspirin twice a day). However, these doses can have a higher incidence of serious gastrointestinal bleeding, and reduced doses (even the low doses recommended for cardiovascular health (81 mg/day)) also seem to have an anti-cancer effect, albeit not as much as the higher doses. The results of these studies have been correlated with experimental studies in human volunteers and in rodents. At least four clinical trials show that small doses of aspirin reduce, modestly, intestinal polyps recurrence in patients with some history of adenomas. <sup id="_ref-10" class="reference"><a href="#_note-10" title="">[24]</a></sup> Some twenty carcinogenesis studies in rats or mice also support that aspirin can prevent cancer, also reported in the <a href="http://www.inra.fr/reseau-nacre/sci-memb/corpet/MAaspirin.html" class="external text" title="http://www.inra.fr/reseau-nacre/sci-memb/corpet/MAaspirin.html" rel="nofollow">Chemoprevention of Colorectal Cancer Database</a>.</li>
</ul>
<ul>
<li><b>Gall bladder</b> - There is some evidence that aspirin may increase gall bladder motility and thus be effective in treating gall bladder disease.<sup class="noprint Template-Fact"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since February 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup></li>
</ul>
<ul>
<li><b>Pancreatic</b> - A study in 2004 showed that increases in dose and duration of aspirin may <i>significantly increase</i> the risk of pancreatic cancer in women (only women were in the study); however this did not seem to affect current, regular users.<sup id="_ref-11" class="reference"><a href="#_note-11" title="">[25]</a></sup></li>
</ul>
<ul>
<li><b>Upper GI tract</b> - A study published in 2003 reported that people who had been taking aspirin regularly for 5 or more years seemed to have a two-thirds less risk of mouth, throat and esophageal cancer than non-users.<sup id="_ref-12" class="reference"><a href="#_note-12" title="">[26]</a></sup> This study was done on both cancer patients and other people in hospital for various reasons, and was done by comprehensive epidemiological questionnaires of life habits rather than empirical testing.</li>
</ul>
<ul>
<li><b>Lung</b> - A 20-year study published in 2002 showed that in a group of 14,000 women in New York City, regular aspirin use (defined as at least once a week, various doses) reduced their risk of lung cancer, especially small-cell carcinoma.<sup id="_ref-13" class="reference"><a href="#_note-13" title="">[27]</a></sup> This may be because many lung tumors have high amounts of COX-2 enzymes expressed in them, especially in adenocarcinomas and tumors caused by <a href="../../../a/s/b/Asbestosis.html" title="Asbestosis">asbestosis</a>.<sup id="_ref-14" class="reference"><a href="#_note-14" title="">[28]</a></sup> Aspirin is a known blocker of both COX-1 and COX-2 enzymes, although this study suggests that if the COX-2 link is direct, other COX-2 inhibitors may also play a similar role.<br />
Another study in 2002 of both men and women found that risk reduction was more significant in males than females; overall, the effects of smoking were far more influential than aspirin use in determining cancer risks.<sup id="_ref-15" class="reference"><a href="#_note-15" title="">[29]</a></sup> Of those who smoked, those who smoked the least got the most benefit from aspirin use. Some of the heaviest smokers saw no benefit from aspirin at all.</li>
</ul>
<p><a name="Aspirin_in_pets" id="Aspirin_in_pets"></a></p>
<h2><span class="editsection">[<a href="../../../a/s/p/Aspirin.html" title="Edit section: Aspirin in pets">edit</a>]</span> <span class="mw-headline">Aspirin in pets</span></h2>
<p>Aspirin may be used in cats, but only under a veterinarian's strict supervision, as aspirin has a biological half-life of 3 days in cats (cats have trouble breaking down aspirin). Dogs may also use aspirin under a vet's strict supervision, though dogs are more susceptible to aspirin-caused GI bleeds than humans. Aspirin is generally not recommended for pets, though, as there are much safer alternatives for pain relief, and aspirin interacts with several other drugs including <a href="../../../c/o/r/Corticosteroid.html" title="Corticosteroid">cortisones</a>, <a href="../../../d/i/g/Digoxin.html" title="Digoxin">digoxin</a>, some antibiotics, <a href="../../../p/h/e/Phenobarbital.html" title="Phenobarbital">phenobarbital</a> and <a href="../../../f/u/r/Furosemide.html" title="Furosemide">furosemide</a> (Lasix).<sup id="_ref-16" class="reference"><a href="#_note-16" title="">[30]</a></sup></p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="../../../a/s/p/Aspirin.html" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="../../../c/o/p/Copper_aspirinate.html" title="Copper aspirinate">Copper aspirinate</a></li>
<li><a href="../../../s/a/l/Salicylic_acid.html" title="Salicylic acid">Salicylic acid</a></li>
</ul>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="../../../a/s/p/Aspirin.html" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<div class="infobox sisterproject">
<div class="floatleft"><span><a href="../../../c/o/m/Image%7ECommons-logo.svg_62a0.html" class="image" title=" "><img src="../../../upload/thumb/4/4a/Commons-logo.svg/50px-Commons-logo.svg.png" alt=" " width="50" height="67" longdesc="../../../c/o/m/Image%7ECommons-logo.svg_62a0.html" /></a></span></div>
<div style="margin-left: 60px;">Wikimedia Commons has media related to:
<div style="margin-left: 10px;"><i><b><a href="http://commons.wikimedia.org/wiki/Aspirin" class="extiw" title="commons:Aspirin">Aspirin</a></b></i></div>
</div>
</div>
<ul>
<li><a href="http://redpoll.pharmacy.ualberta.ca/drugbank/cgi-bin/getCard.cgi?CARD=APRD00264" class="external text" title="http://redpoll.pharmacy.ualberta.ca/drugbank/cgi-bin/getCard.cgi?CARD=APRD00264" rel="nofollow">DrugBank Aspirin Entry</a></li>
<li><a href="http://bmj.bmjjournals.com/cgi/content/full/321/7276/1591" class="external text" title="http://bmj.bmjjournals.com/cgi/content/full/321/7276/1591" rel="nofollow">Reappraisal</a></li>
<li><a href="http://almaz.com/nobel/medicine/aspirin.html" class="external text" title="http://almaz.com/nobel/medicine/aspirin.html" rel="nofollow">An aspirin a day keeps the doctor away</a></li>
<li><a href="http://www.wellcome.ac.uk/en/bia/gallery.html?image=24" class="external text" title="http://www.wellcome.ac.uk/en/bia/gallery.html?image=24" rel="nofollow">Colour-enhanced scanning electron micrograph of aspirin crystals</a></li>
<li><a href="http://chemed.chem.purdue.edu/genchem/topicreview/bp/1biochem/research7.html" class="external text" title="http://chemed.chem.purdue.edu/genchem/topicreview/bp/1biochem/research7.html" rel="nofollow">Aspirin research in the 1990s</a></li>
<li><a href="http://www.med.mcgill.ca/mjm/issues/v02n02/aspirin.html" class="external text" title="http://www.med.mcgill.ca/mjm/issues/v02n02/aspirin.html" rel="nofollow">The History of Aspirin</a></li>
<li><a href="http://www.jhu.edu/~jhumag/0297web/health.html" class="external text" title="http://www.jhu.edu/~jhumag/0297web/health.html" rel="nofollow">Aspirin and heart disease</a></li>
<li><a href="http://www.howstuffworks.com/aspirin" class="external text" title="http://www.howstuffworks.com/aspirin" rel="nofollow">How Aspirin works</a></li>
<li><a href="http://www.bluerhinos.co.uk/molview/indv.php?id=5" class="external text" title="http://www.bluerhinos.co.uk/molview/indv.php?id=5" rel="nofollow">Molview from bluerhinos.co.uk</a> See Aspirin in 3D</li>
<li><a href="http://www.creatingtechnology.org/biomed/aspirin.htm" class="external text" title="http://www.creatingtechnology.org/biomed/aspirin.htm" rel="nofollow">The science behind aspirin</a></li>
<li><cite style="font-style:normal">Ling, Greg. (2005). "<a href="http://www.madehow.com/Volume-1/Aspirin.html" class="external text" title="http://www.madehow.com/Volume-1/Aspirin.html" rel="nofollow">Aspirin</a>". <i>How Products are Made</i> <b>1</b>.  Thomson Gale.</cite></li>
<li><a href="../../../c/h/e/Wikipedia%7EChemical_sources_67a4.html" title="Wikipedia:Chemical sources">Links to external chemical sources</a></li>
</ul>
<p><a name="Footnotes" id="Footnotes"></a></p>
<h2><span class="editsection">[<a href="../../../a/s/p/Aspirin.html" title="Edit section: Footnotes">edit</a>]</span> <span class="mw-headline">Footnotes</span></h2>
<div class="references-small">
<ol class="references">
<li id="_note-BMJ2002-Macdonald">^ <a href="#_ref-BMJ2002-Macdonald_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-BMJ2002-Macdonald_1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal">Macdonald S (2002). "Aspirin use to be banned in under 16 year olds". <i>BMJ</i> <b>325</b> (7371): 988. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12411346" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12411346">PMID 12411346</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Aspirin+use+to+be+banned+in+under+16+year+olds&amp;rft.title=BMJ&amp;rft.jtitle=BMJ&amp;rft.date=2002&amp;rft.volume=325&amp;rft.issue=7371&amp;rft.au=Macdonald+S&amp;rft.pages=988&amp;rft_id=info:pmid/12411346">&#160;</span></li>
<li id="_note-0"><b><a href="#_ref-0" title="">^</a></b> Paul B. Hemel and Mary U. Chiltoskey, <i>Cherokee Plants and Their Uses -- A 400 Year History,</i> Sylva, NC: Herald Publishing Co. (1975); cited in Dan Moerman, A Database of Foods, Drugs, Dyes and Fibers of Native American Peoples, Derived from Plants.<a href="http://herb.umd.umich.edu/" class="external autonumber" title="http://herb.umd.umich.edu/" rel="nofollow">[1]</a> A search of this database for "salix AND medicine" finds 63 entries.</li>
<li id="_note-RoyalSoc1763EdmundStone"><b><a href="#_ref-RoyalSoc1763EdmundStone_0" title="">^</a></b> <cite style="font-style:normal">Stone, E (1763). "<a href="http://www.journals.royalsoc.ac.uk/openurl.asp?genre=article&amp;issn=0260-7085&amp;volume=53&amp;spage=195" class="external text" title="http://www.journals.royalsoc.ac.uk/openurl.asp?genre=article&amp;issn=0260-7085&amp;volume=53&amp;spage=195" rel="nofollow">An Account of the Success of the Bark of the Willow in the Cure of Agues</a>". <i>Philosophical Transactions</i> <b>53</b>: 195-200.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=An+Account+of+the+Success+of+the+Bark+of+the+Willow+in+the+Cure+of+Agues&amp;rft.title=Philosophical+Transactions&amp;rft.jtitle=Philosophical+Transactions&amp;rft.date=1763&amp;rft.volume=53&amp;rft.au=Stone%2C+E&amp;rft.pages=195-200&amp;rft_id=http%3A%2F%2Fwww.journals.royalsoc.ac.uk%2Fopenurl.asp%3Fgenre%3Darticle%26issn%3D0260-7085%26volume%3D53%26spage%3D195">&#160;</span></li>
<li id="_note-asaaciddissconst"><b><a href="#_ref-asaaciddissconst_0" title="">^</a></b> <a href="http://chrom.tutms.tut.ac.jp/JINNO/DRUGDATA/07acetylsalicylic_acid.html" class="external text" title="http://chrom.tutms.tut.ac.jp/JINNO/DRUGDATA/07acetylsalicylic_acid.html" rel="nofollow">Acetylsalicylic acid</a>. Jinno Laboratory, School of Materials Science, Toyohashi University of Technology (1996).</li>
<li id="_note-1"><b><a href="#_ref-1" title="">^</a></b> <cite style="font-style:normal">John Robert Vane (1971). "Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.". <i>Nature - New Biology</i> <b>231</b> (25): 232-5. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=5284360" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=5284360">PMID 5284360</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Inhibition+of+prostaglandin+synthesis+as+a+mechanism+of+action+for+aspirin-like+drugs.&amp;rft.title=Nature+-+New+Biology&amp;rft.jtitle=Nature+-+New+Biology&amp;rft.date=1971&amp;rft.volume=231&amp;rft.issue=25&amp;rft.au=John+Robert+Vane&amp;rft.pages=232-5&amp;rft_id=info:pmid/5284360">&#160;</span></li>
<li id="_note-2"><b><a href="#_ref-2" title="">^</a></b> <a href="http://www.medicalnewstoday.com/medicalnews.php?newsid=31435" class="external text" title="http://www.medicalnewstoday.com/medicalnews.php?newsid=31435" rel="nofollow">"New mechanism of action of Aspirin discovered,"</a> in <i>Medical News Today</i>, October 2, 2005.</li>
<li id="_note-Lancet1988-ISIS2"><b><a href="#_ref-Lancet1988-ISIS2_0" title="">^</a></b> <cite style="font-style:normal">ISIS-2 Collaborative group (1988). "Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.". <i>Lancet</i> (2): 349-60. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2899772" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2899772">PMID 2899772</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Randomized+trial+of+intravenous+streptokinase%2C+oral+aspirin%2C+both%2C+or+neither+among+17%2C187+cases+of+suspected+acute+myocardial+infarction%3A+ISIS-2.&amp;rft.title=Lancet&amp;rft.jtitle=Lancet&amp;rft.date=1988&amp;rft.issue=2&amp;rft.au=ISIS-2+Collaborative+group&amp;rft.pages=349-60&amp;rft_id=info:pmid/2899772">&#160;</span></li>
<li id="_note-3"><b><a href="#_ref-3" title="">^</a></b> <cite class="book" style="font-style:normal">(March 2003) <i><a href="../../../b/r/i/British_National_Formulary_b331.html" title="British National Formulary">British National Formulary</a></i>, 45, <a href="../../../b/r/i/British_Medical_Journal_9f3e.html" title="British Medical Journal">British Medical Journal</a> and <a href="../../../r/o/y/Royal_Pharmaceutical_Society_of_Great_Britain_b4b6.html" title="Royal Pharmaceutical Society of Great Britain">Royal Pharmaceutical Society of Great Britain</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=%5B%5BBritish+National+Formulary%5D%5D&amp;rft.title=%5B%5BBritish+National+Formulary%5D%5D&amp;rft.date=March+2003&amp;rft.edition=45&amp;rft.pub=%5B%5BBritish+Medical+Journal%5D%5D+and+%5B%5BRoyal+Pharmaceutical+Society+of+Great+Britain%5D%5D">&#160;</span></li>
<li id="_note-4"><b><a href="#_ref-4" title="">^</a></b> <cite class="book" style="font-style:normal">(2006) <i><a href="../../../b/r/i/British_National_Formulary_for_Children_5683.html" title="British National Formulary for Children">British National Formulary for Children</a></i>. <a href="../../../b/r/i/British_Medical_Journal_9f3e.html" title="British Medical Journal">British Medical Journal</a> and <a href="../../../r/o/y/Royal_Pharmaceutical_Society_of_Great_Britain_b4b6.html" title="Royal Pharmaceutical Society of Great Britain">Royal Pharmaceutical Society of Great Britain</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=%5B%5BBritish+National+Formulary+for+Children%5D%5D&amp;rft.title=%5B%5BBritish+National+Formulary+for+Children%5D%5D&amp;rft.date=2006&amp;rft.pub=%5B%5BBritish+Medical+Journal%5D%5D+and+%5B%5BRoyal+Pharmaceutical+Society+of+Great+Britain%5D%5D">&#160;</span></li>
<li id="_note-AmJMed2006-ASAClopidogrelReviewArticle"><b><a href="#_ref-AmJMed2006-ASAClopidogrelReviewArticle_0" title="">^</a></b> <cite style="font-style:normal">McQuaid KR, Laine L. (2006). "Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials.". <i>Am J Med</i> <b>119</b> (8): 624-38. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16887404" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16887404">PMID 16887404</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Systematic+review+and+meta-analysis+of+adverse+events+of+low-dose+aspirin+and+clopidogrel+in+randomized+controlled+trials.&amp;rft.title=Am+J+Med&amp;rft.jtitle=Am+J+Med&amp;rft.date=2006&amp;rft.volume=119&amp;rft.issue=8&amp;rft.au=McQuaid+KR%2C+Laine+L.&amp;rft.pages=624-38&amp;rft_id=info:pmid/16887404">&#160;</span></li>
<li id="_note-Pediatrics1982-gaudreault"><b><a href="#_ref-Pediatrics1982-gaudreault_0" title="">^</a></b> <cite style="font-style:normal">Gaudreault P, Temple AR, Lovejoy FH Jr. (1982). "The relative severity of acute versus chronic salicylate poisoning in children: a clinical comparison". <i>Pediatrics</i> <b>70</b> (4): 566-9. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7122154" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7122154">PMID 7122154</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=The+relative+severity+of+acute+versus+chronic+salicylate+poisoning+in+children%3A+a+clinical+comparison&amp;rft.title=Pediatrics&amp;rft.jtitle=Pediatrics&amp;rft.date=1982&amp;rft.volume=70&amp;rft.issue=4&amp;rft.au=Gaudreault+P%2C+Temple+AR%2C+Lovejoy+FH+Jr.&amp;rft.pages=566-9&amp;rft_id=info:pmid/7122154">&#160;</span></li>
<li id="_note-ActaAnaesthesiol1987-Thisted"><b><a href="#_ref-ActaAnaesthesiol1987-Thisted_0" title="">^</a></b> <cite style="font-style:normal">Thisted B, Krantz T, Stroom J, Sorensen MB. (1987). "Acute salicylate self-poisoning in 177 consecutive patients treated in ICU". <i>Acta Anaesthesiol Scand</i> <b>31</b> (4): 312-6. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=3591255" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=3591255">PMID 3591255</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Acute+salicylate+self-poisoning+in+177+consecutive+patients+treated+in+ICU&amp;rft.title=Acta+Anaesthesiol+Scand&amp;rft.jtitle=Acta+Anaesthesiol+Scand&amp;rft.date=1987&amp;rft.volume=31&amp;rft.issue=4&amp;rft.au=Thisted+B%2C+Krantz+T%2C+Stroom+J%2C+Sorensen+MB.&amp;rft.pages=312-6&amp;rft_id=info:pmid/3591255">&#160;</span></li>
<li id="_note-ArchInternMed1981-Temple"><b><a href="#_ref-ArchInternMed1981-Temple_0" title="">^</a></b> <cite style="font-style:normal">Temple AR. (1981). "Acute and chronic effects of aspirin toxicity and their treatment". <i>Arch Intern Med</i> <b>141</b> (3 Spec No): 364-9. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7469627" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7469627">PMID 7469627</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Acute+and+chronic+effects+of+aspirin+toxicity+and+their+treatment&amp;rft.title=Arch+Intern+Med&amp;rft.jtitle=Arch+Intern+Med&amp;rft.date=1981&amp;rft.volume=141&amp;rft.issue=3+Spec+No&amp;rft.au=Temple+AR.&amp;rft.pages=364-9&amp;rft_id=info:pmid/7469627">&#160;</span></li>
<li id="_note-5"><b><a href="#_ref-5" title="">^</a></b> <cite style="font-style:normal">Vale JA, Kulig K; American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. (2004). "Position paper: gastric lavage.". <i>J Toxicol Clin Toxicol</i> <b>42</b> (7): 933-43. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15641639" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15641639">PMID 15641639</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Position+paper%3A+gastric+lavage.&amp;rft.title=J+Toxicol+Clin+Toxicol&amp;rft.jtitle=J+Toxicol+Clin+Toxicol&amp;rft.date=2004&amp;rft.volume=42&amp;rft.issue=7&amp;rft.au=Vale+JA%2C+Kulig+K%3B+American+Academy+of+Clinical+Toxicology%3B+European+Association+of+Poisons+Centres+and+Clinical+Toxicologists.&amp;rft.pages=933-43&amp;rft_id=info:pmid/15641639">&#160;</span></li>
<li id="_note-BMJ1985-hillman"><b><a href="#_ref-BMJ1985-hillman_0" title="">^</a></b> <cite style="font-style:normal">Hillman RJ, Prescott LF. (1985). "Treatment of salicylate poisoning with repeated oral charcoal". <i>Br Med J (Clin Res Ed)</i> <b>291</b> (6507): 1472. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=3933714" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=3933714">PMID 3933714</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Treatment+of+salicylate+poisoning+with+repeated+oral+charcoal&amp;rft.title=Br+Med+J+%28Clin+Res+Ed%29&amp;rft.jtitle=Br+Med+J+%28Clin+Res+Ed%29&amp;rft.date=1985&amp;rft.volume=291&amp;rft.issue=6507&amp;rft.au=Hillman+RJ%2C+Prescott+LF.&amp;rft.pages=1472&amp;rft_id=info:pmid/3933714">&#160;</span></li>
<li id="_note-ArchInternMed1990-Kirshenbaum"><b><a href="#_ref-ArchInternMed1990-Kirshenbaum_0" title="">^</a></b> <cite style="font-style:normal">Kirshenbaum LA, Mathews SC, Sitar DS, Tenenbein M. (1990). "Does multiple-dose charcoal therapy enhance salicylate excretion?". <i>Arch Intern Med</i> <b>150</b> (6): 1281-3. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2191636" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2191636">PMID 2191636</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Does+multiple-dose+charcoal+therapy+enhance+salicylate+excretion%3F&amp;rft.title=Arch+Intern+Med&amp;rft.jtitle=Arch+Intern+Med&amp;rft.date=1990&amp;rft.volume=150&amp;rft.issue=6&amp;rft.au=Kirshenbaum+LA%2C+Mathews+SC%2C+Sitar+DS%2C+Tenenbein+M.&amp;rft.pages=1281-3&amp;rft_id=info:pmid/2191636">&#160;</span></li>
<li id="_note-EmergMed2002-Dargan">^ <a href="#_ref-EmergMed2002-Dargan_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-EmergMed2002-Dargan_1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal">Dargan PI, Wallace CI, Jones AL. (2002). "An evidenced based flowchart to guide the management of acute salicylate (aspirin) overdose". <i>Emerg Med J</i> <b>19</b> (3): 206-9. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11971828" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11971828">PMID 11971828</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=An+evidenced+based+flowchart+to+guide+the+management+of+acute+salicylate+%28aspirin%29+overdose&amp;rft.title=Emerg+Med+J&amp;rft.jtitle=Emerg+Med+J&amp;rft.date=2002&amp;rft.volume=19&amp;rft.issue=3&amp;rft.au=Dargan+PI%2C+Wallace+CI%2C+Jones+AL.&amp;rft.pages=206-9&amp;rft_id=info:pmid/11971828">&#160;</span></li>
<li id="_note-drugs1986-Meredith"><b><a href="#_ref-drugs1986-Meredith_0" title="">^</a></b> <cite style="font-style:normal">Meredith TJ, Vale JA. (1986). "Non-narcotic analgesics. Problems of overdosage". <i>Drugs</i> <b>32</b> (Suppl 4): 117-205. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=3552583" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=3552583">PMID 3552583</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Non-narcotic+analgesics.+Problems+of+overdosage&amp;rft.title=Drugs&amp;rft.jtitle=Drugs&amp;rft.date=1986&amp;rft.volume=32&amp;rft.issue=Suppl+4&amp;rft.au=Meredith+TJ%2C+Vale+JA.&amp;rft.pages=117-205&amp;rft_id=info:pmid/3552583">&#160;</span></li>
<li id="_note-AmJEmergMed2001-Litovitz"><b><a href="#_ref-AmJEmergMed2001-Litovitz_0" title="">^</a></b> <cite style="font-style:normal">Litovitz TL, Klein-Schwartz W, White S, Cobaugh DJ, Youniss J, Omslaer JC, Drab A, Benson BE (2001). "2000 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System". <i>Am J Emerg Med</i> <b>19</b> (5): 337-95. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11555795" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11555795">PMID 11555795</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=2000+Annual+report+of+the+American+Association+of+Poison+Control+Centers+Toxic+Exposure+Surveillance+System&amp;rft.title=Am+J+Emerg+Med&amp;rft.jtitle=Am+J+Emerg+Med&amp;rft.date=2001&amp;rft.volume=19&amp;rft.issue=5&amp;rft.au=Litovitz+TL%2C+Klein-Schwartz+W%2C+White+S%2C+Cobaugh+DJ%2C+Youniss+J%2C+Omslaer+JC%2C+Drab+A%2C+Benson+BE&amp;rft.pages=337-95&amp;rft_id=info:pmid/11555795">&#160;</span></li>
<li id="_note-6"><b><a href="#_ref-6" title="">^</a></b> <cite style="font-style:normal">Bosetti, <i>et al.</i> (2006). "Aspirin and the risk of prostate cancer". <i>Eur J Cancer Prev</i> <b>15</b> (1): 43-5. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16374228" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16374228">PMID 16374228</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Aspirin+and+the+risk+of+prostate+cancer&amp;rft.title=Eur+J+Cancer+Prev&amp;rft.jtitle=Eur+J+Cancer+Prev&amp;rft.date=2006&amp;rft.volume=15&amp;rft.issue=1&amp;rft.au=Bosetti%2C+%27%27et+al.%27%27&amp;rft.pages=43-5&amp;rft_id=info:pmid/16374228">&#160;</span></li>
<li id="_note-7"><b><a href="#_ref-7" title="">^</a></b> <cite style="font-style:normal">Menezes, <i>et al.</i> (2006). "Regular use of aspirin and prostate cancer risk (United States)". <i>Cancer Causes Control</i> <b>17</b> (3): 251-6. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16489532" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16489532">PMID 16489532</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Regular+use+of+aspirin+and+prostate+cancer+risk+%28United+States%29&amp;rft.title=Cancer+Causes+Control&amp;rft.jtitle=Cancer+Causes+Control&amp;rft.date=2006&amp;rft.volume=17&amp;rft.issue=3&amp;rft.au=Menezes%2C+%27%27et+al.%27%27&amp;rft.pages=251-6&amp;rft_id=info:pmid/16489532">&#160;</span></li>
<li id="_note-8"><b><a href="#_ref-8" title="">^</a></b> <cite style="font-style:normal">Chan, <i>et al.</i> (2005). "Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal Cancer". <i>JAMA</i> <b>294</b> (8): 914-23. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16118381" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16118381">PMID 16118381</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Long-term+Use+of+Aspirin+and+Nonsteroidal+Anti-inflammatory+Drugs+and+Risk+of+Colorectal+Cancer&amp;rft.title=JAMA&amp;rft.jtitle=JAMA&amp;rft.date=2005&amp;rft.volume=294&amp;rft.issue=8&amp;rft.au=Chan%2C+%27%27et+al.%27%27&amp;rft.pages=914-23&amp;rft_id=info:pmid/16118381">&#160;</span></li>
<li id="_note-9"><b><a href="#_ref-9" title="">^</a></b> <cite style="font-style:normal">Chan, <i>et al.</i> (2004). "A Prospective Study of Aspirin Use and the Risk for Colorectal Adenoma". <i>Ann Intern Med</i> <b>140</b> (3): 157-66. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14757613" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14757613">PMID 14757613</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=A+Prospective+Study+of+Aspirin+Use+and+the+Risk+for+Colorectal+Adenoma&amp;rft.title=Ann+Intern+Med&amp;rft.jtitle=Ann+Intern+Med&amp;rft.date=2004&amp;rft.volume=140&amp;rft.issue=3&amp;rft.au=Chan%2C+%27%27et+al.%27%27&amp;rft.pages=157-66&amp;rft_id=info:pmid/14757613">&#160;</span></li>
<li id="_note-10"><b><a href="#_ref-10" title="">^</a></b> <cite style="font-style:normal">Baron, <i>et al.</i> (2003). "A randomized trial of aspirin to prevent colorectal adenomas". <i>N Engl J Med</i> <b>348</b> (10): 891-9. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12621133" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12621133">PMID 12621133</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=A+randomized+trial+of+aspirin+to+prevent+colorectal+adenomas&amp;rft.title=N+Engl+J+Med&amp;rft.jtitle=N+Engl+J+Med&amp;rft.date=2003&amp;rft.volume=348&amp;rft.issue=10&amp;rft.au=Baron%2C+%27%27et+al.%27%27&amp;rft.pages=891-9&amp;rft_id=info:pmid/12621133">&#160;</span></li>
<li id="_note-11"><b><a href="#_ref-11" title="">^</a></b> <cite style="font-style:normal">Schernhammer, <i>et al.</i> (2004). "A Prospective Study of Aspirin Use and the Risk of Pancreatic Cancer in Women". <i>J Natl Cancer Inst</i> <b>96</b> (1): 22-28. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14709735" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14709735">PMID 14709735</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=A+Prospective+Study+of+Aspirin+Use+and+the+Risk+of+Pancreatic+Cancer+in+Women&amp;rft.title=J+Natl+Cancer+Inst&amp;rft.jtitle=J+Natl+Cancer+Inst&amp;rft.date=2004&amp;rft.volume=96&amp;rft.issue=1&amp;rft.au=Schernhammer%2C+%27%27et+al.%27%27&amp;rft.pages=22-28&amp;rft_id=info:pmid/14709735">&#160;</span></li>
<li id="_note-12"><b><a href="#_ref-12" title="">^</a></b> <cite style="font-style:normal">Bosetti, <i>et al.</i> (2003). "Aspirin use and cancers of the upper aerodigestive tract". <i>Br J Cancer</i> <b>88</b> (5): 672-74. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12618872" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12618872">PMID 12618872</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Aspirin+use+and+cancers+of+the+upper+aerodigestive+tract&amp;rft.title=Br+J+Cancer&amp;rft.jtitle=Br+J+Cancer&amp;rft.date=2003&amp;rft.volume=88&amp;rft.issue=5&amp;rft.au=Bosetti%2C+%27%27et+al.%27%27&amp;rft.pages=672-74&amp;rft_id=info:pmid/12618872">&#160;</span></li>
<li id="_note-13"><b><a href="#_ref-13" title="">^</a></b> <cite style="font-style:normal">Akhmedkhanov, <i>et al.</i> (2002). "Aspirin and lung cancer in women". <i>Br J cancer</i> <b>87</b> (11): 1337-8. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12085255" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12085255">PMID 12085255</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Aspirin+and+lung+cancer+in+women&amp;rft.title=Br+J+cancer&amp;rft.jtitle=Br+J+cancer&amp;rft.date=2002&amp;rft.volume=87&amp;rft.issue=11&amp;rft.au=Akhmedkhanov%2C+%27%27et+al.%27%27&amp;rft.pages=1337-8&amp;rft_id=info:pmid/12085255">&#160;</span></li>
<li id="_note-14"><b><a href="#_ref-14" title="">^</a></b> <cite style="font-style:normal">Wolff, <i>et al.</i> (1998). "<a href="http://cancerres.aacrjournals.org/cgi/content/abstract/58/22/4997" class="external text" title="http://cancerres.aacrjournals.org/cgi/content/abstract/58/22/4997" rel="nofollow">Expression of cyclooxygenase-2 in human lung carcinoma</a>". <i>Cancer Research</i> <b>58</b> (22): 4997-5001.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Expression+of+cyclooxygenase-2+in+human+lung+carcinoma&amp;rft.title=Cancer+Research&amp;rft.jtitle=Cancer+Research&amp;rft.date=1998&amp;rft.volume=58&amp;rft.issue=22&amp;rft.au=Wolff%2C+%27%27et+al.%27%27&amp;rft.pages=4997-5001&amp;rft_id=http%3A%2F%2Fcancerres.aacrjournals.org%2Fcgi%2Fcontent%2Fabstract%2F58%2F22%2F4997">&#160;</span></li>
<li id="_note-15"><b><a href="#_ref-15" title="">^</a></b> <cite style="font-style:normal">Moysich, <i>et al.</i> (2002). "<a href="http://www.biomedcentral.com/1471-2407/2/31" class="external text" title="http://www.biomedcentral.com/1471-2407/2/31" rel="nofollow">Regular aspirin use and lung cancer risk</a>" <b>2</b> (31).</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Regular+aspirin+use+and+lung+cancer+risk&amp;rft.date=2002&amp;rft.volume=2&amp;rft.issue=31&amp;rft.au=Moysich%2C+%27%27et+al.%27%27&amp;rft_id=http%3A%2F%2Fwww.biomedcentral.com%2F1471-2407%2F2%2F31">&#160;</span></li>
<li id="_note-16"><b><a href="#_ref-16" title="">^</a></b> Crosby, Janet Tobiassen (2006). <a href="http://vetmedicine.about.com/cs/altvetmedgeneral/a/dogcataspirin.htm" class="external text" title="http://vetmedicine.about.com/cs/altvetmedgeneral/a/dogcataspirin.htm" rel="nofollow">Veterinary Questions and Answers</a>. About.com.</li>
</ol>
</div>
<table class="navbox collapsible" style="margin:auto;">
<tr>
<th colspan="2" style="text-align:center;">
<div style="float:left; width:6em; text-align:left;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap;"><a href="../../../a/n/a/Template%7EAnalgesics_c4d0.html" title="Template:Analgesics"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="../../../a/n/a/Template_talk%7EAnalgesics_d7d8.html" title="Template talk:Analgesics"><span title="Discussion about this template">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../a/n/a/Template%7EAnalgesics_c4d0.html" class="external text" title="http://en.wikipedia.org../../../a/n/a/Template%7EAnalgesics_c4d0.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="../../../a/n/a/Analgesic.html" title="Analgesic">Analgesics</a> (<a href="../../../a/t/c/ATC_code_N02_38b2.html#N02A_Opioids" title="ATC code N02">N02A</a>, <a href="../../../a/t/c/ATC_code_N02_38b2.html#N02B_Other_analgesics_and_antipyretics" title="ATC code N02">N02B</a>)</span></th>
</tr>
<tr>
<th style=""><a href="../../../o/p/i/Opioids.html" title="Opioids">Opioids</a></th>
<td style="" colspan="1"><a href="../../../b/e/z/Bezitramide.html" title="Bezitramide">Bezitramide</a>, <a href="../../../b/u/p/Buprenorphine.html" title="Buprenorphine">Buprenorphine</a>, <a href="../../../b/u/t/Butorphanol.html" title="Butorphanol">Butorphanol</a>, <a href="../../../d/e/x/Dextromoramide.html" title="Dextromoramide">Dextromoramide</a>, <a href="../../../d/e/x/Dextropropoxyphene.html" title="Dextropropoxyphene">Dextropropoxyphene</a>, <a href="../../../d/i/a/Diamorphine.html" title="Diamorphine">Diamorphine</a>, <a href="../../../d/i/h/Dihydrocodeine.html" title="Dihydrocodeine">Dihydrocodeine</a>, <a href="../../../f/e/n/Fentanyl.html" title="Fentanyl">Fentanyl</a>, <a href="../../../h/y/d/Hydromorphone.html" title="Hydromorphone">Hydromorphone</a>, <a href="../../../k/e/t/Ketobemidone.html" title="Ketobemidone">Ketobemidone</a>, <a href="../../../m/e/t/Methadone.html" title="Methadone">Methadone</a>, <a href="../../../m/o/r/Morphine.html" title="Morphine">Morphine</a>, <a href="../../../n/a/l/Nalbufine.html" title="Nalbufine">Nalbufine</a>, <a href="../../../n/i/c/Nicomorphine.html" title="Nicomorphine">Nicomorphine</a>, <a href="../../../o/p/i/Opium.html" title="Opium">Opium</a>, <a href="../../../o/x/y/Oxycodone.html" title="Oxycodone">Oxycodone</a>, <a href="../../../p/a/p/Papaveretum.html" title="Papaveretum">Papaveretum</a>, <a href="../../../p/e/t/Pethidine.html" title="Pethidine">Pethidine</a>, <a href="../../../p/i/r/Piritramide.html" title="Piritramide">Piritramide</a>, <a href="../../../t/r/a/Tramadol.html" title="Tramadol">Tramadol</a> <i>(see also <a href="../../../o/p/i/Template%7EOpioids_708c.html" title="Template:Opioids">longer list</a>)</i></td>
</tr>
<tr>
<th style=""><a href="../../../s/a/l/Salicylic_acid.html" title="Salicylic acid">Salicylic acid</a> and derivatives</th>
<td style="" colspan="1"><strong class="selflink">Aspirin</strong> (Acetylsalicylic Acid), <a href="../../../d/i/f/Diflunisal.html" title="Diflunisal">Diflunisal</a>, <a href="../../../e/t/h/Ethenzamide.html" title="Ethenzamide">Ethenzamide</a> <font color="#000000">-- <i>See also:</i></font> <b><a href="../../../n/s/a/Template%7ENSAIDs_d8fb.html" title="Template:NSAIDs">NSAIDs</a></b></td>
</tr>
<tr>
<th style=""><a href="../../../p/y/r/Pyrazolones.html" title="Pyrazolones">Pyrazolones</a></th>
<td style="" colspan="1"><a href="../../../a/m/i/Aminophenazone.html" title="Aminophenazone">Aminophenazone</a>, <a href="../../../m/e/t/Metamizole.html" title="Metamizole">Metamizole</a>, <a href="../../../p/h/e/Phenazone.html" title="Phenazone">Phenazone</a></td>
</tr>
<tr>
<th style=""><a href="../../../a/n/i/Anilides.html" title="Anilides">Anilides</a></th>
<td style="" colspan="1"><a href="../../../p/a/r/Paracetamol.html" title="Paracetamol">Paracetamol (acetaminophen)</a>, <a href="../../../p/h/e/Phenacetin.html" title="Phenacetin">Phenacetin</a></td>
</tr>
<tr>
<th style="">Others</th>
<td style="" colspan="1"><a href="../../../z/i/c/Ziconotide.html" title="Ziconotide">Ziconotide</a>, <a href="../../../t/e/t/Tetrahydrocannabinol.html" title="Tetrahydrocannabinol">Tetrahydrocannabinol</a>, <a href="../../../i/b/u/Ibuprofen.html" title="Ibuprofen">Ibuprofen</a>, <a href="../../../k/e/t/Ketoprofen.html" title="Ketoprofen">Ketoprofen</a>, <a href="../../../m/e/f/Mefenamic_Acid_4985.html" title="Mefenamic Acid">Mefenamic Acid</a>, <a href="../../../n/a/p/Naproxen.html" title="Naproxen">Naproxen</a>, <a href="../../../d/i/c/Diclofenac.html" title="Diclofenac">Diclofenac</a>, <a href="../../../f/l/u/Flurbiprofen.html" title="Flurbiprofen">Flurbiprofen</a>, <a href="../../../d/i/f/Diflunisal.html" title="Diflunisal">Diflunisal</a>, Fenoprofen, <a href="../../../i/n/d/Indomethacin.html" title="Indomethacin">Indomethacin</a>, <a href="../../../k/e/t/Ketorolac.html" title="Ketorolac">Ketorolac</a>, Meclofenamate, <a href="../../../m/e/l/Meloxicam.html" title="Meloxicam">Meloxicam</a>, <a href="../../../p/i/r/Piroxicam.html" title="Piroxicam">Piroxicam</a>, Tolmetin</td>
</tr>
</table>
<div class="NavFrame" style="clear:both;">
<div class="NavHead" style="background:#ccccff;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap; position:absolute; width:auto; left:0.5em;"><a href="../../../n/s/a/Template%7ENSAIDs_d8fb.html" title="Template:NSAIDs"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<span style="color: #002bb8;" title="Discussion about this template">d</span>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../n/s/a/Template%7ENSAIDs_d8fb.html" class="external text" title="http://en.wikipedia.org../../../n/s/a/Template%7ENSAIDs_d8fb.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
<b><a href="../../../n/o/n/Non-steroidal_anti-inflammatory_drug.html" title="Non-steroidal anti-inflammatory drug">Non-steroidal anti-inflammatory drugs</a> (primarily <a href="../../../a/t/c/ATC_code_M01_5645.html#M01A_Anti-inflammatory_and_antirheumatic_products.2C_non-steroids" title="ATC code M01">M01A</a> and <a href="../../../a/t/c/ATC_code_M02_04f9.html#M02A_Topical_products_for_joint_and_muscular_pain" title="ATC code M02">M02A</a>, also <a href="../../../a/t/c/ATC_code_N02_38b2.html#N02B_Other_analgesics_and_antipyretics" title="ATC code N02">N02BA</a>)</b></div>
<div class="NavContent" style="margin:0.5em; font-size:0.9em;">
<p><b>Salicylates:</b> <strong class="selflink">Aspirin (Acetylsalicylic Acid)</strong>, <a href="../../../d/i/f/Diflunisal.html" title="Diflunisal">Diflunisal</a>, <a href="../../../e/t/h/Ethenzamide.html" title="Ethenzamide">Ethenzamide</a></p>
<p><b>Arylalkanoic acids:</b> <a href="../../../d/i/c/Diclofenac.html" title="Diclofenac">Diclofenac</a>, <a href="../../../i/n/d/Indometacin.html" title="Indometacin">Indometacin</a>, <a href="../../../s/u/l/Sulindac.html" title="Sulindac">Sulindac</a></p>
<p><b>2-Arylpropionic acids (profens):</b> <a href="../../../c/a/r/Carprofen.html" title="Carprofen">Carprofen</a>, <a href="../../../f/l/u/Flurbiprofen.html" title="Flurbiprofen">Flurbiprofen</a>, <a href="../../../i/b/u/Ibuprofen.html" title="Ibuprofen">Ibuprofen</a>, <a href="../../../k/e/t/Ketoprofen.html" title="Ketoprofen">Ketoprofen</a>, <a href="../../../k/e/t/Ketorolac.html" title="Ketorolac">Ketorolac</a>, <a href="../../../l/o/x/Loxoprofen.html" title="Loxoprofen">Loxoprofen</a>, <a href="../../../n/a/p/Naproxen.html" title="Naproxen">Naproxen</a>, <a href="../../../t/i/a/Tiaprofenic_acid.html" title="Tiaprofenic acid">Tiaprofenic acid</a></p>
<p><b>N-Arylanthranilic acids (fenamic acids):</b> <a href="../../../m/e/f/Mefenamic_acid.html" title="Mefenamic acid">Mefenamic acid</a></p>
<p><b>Pyrazolidine derivatives:</b> <a href="../../../p/h/e/Phenylbutazone.html" title="Phenylbutazone">Phenylbutazone</a></p>
<p><b>Oxicams:</b> <a href="../../../m/e/l/Meloxicam.html" title="Meloxicam">Meloxicam</a>, <a href="../../../p/i/r/Piroxicam.html" title="Piroxicam">Piroxicam</a></p>
<p><b>Coxibs:</b> <a href="../../../c/e/l/Celecoxib.html" title="Celecoxib">Celecoxib</a>, <a href="../../../e/t/o/Etoricoxib.html" title="Etoricoxib">Etoricoxib</a>, <a href="../../../p/a/r/Parecoxib.html" title="Parecoxib">Parecoxib</a>, <a href="../../../r/o/f/Rofecoxib.html" title="Rofecoxib">Rofecoxib</a>, <a href="../../../v/a/l/Valdecoxib.html" title="Valdecoxib">Valdecoxib</a></p>
<p><b>Sulphonanilides:</b> <a href="../../../n/i/m/Nimesulide.html" title="Nimesulide">Nimesulide</a></p>
<p><i><b>Topically used products:</b> <a href="../../../d/i/c/Diclofenac.html" title="Diclofenac">Diclofenac</a>, <a href="../../../f/l/u/Flurbiprofen.html" title="Flurbiprofen">Flurbiprofen</a>, <a href="../../../i/b/u/Ibuprofen.html" title="Ibuprofen">Ibuprofen</a>, <a href="../../../i/n/d/Indometacin.html" title="Indometacin">Indometacin</a>, <a href="../../../k/e/t/Ketoprofen.html" title="Ketoprofen">Ketoprofen</a>, <a href="../../../n/a/p/Naproxen.html" title="Naproxen">Naproxen</a>, <a href="../../../p/i/r/Piroxicam.html" title="Piroxicam">Piroxicam</a></i></p>
</div>
</div>
<p><span id="interwiki-fr-fa"></span> <span id="interwiki-he-fa"></span> <span id="interwiki-nl-fa"></span></p>

<!-- 
Pre-expand include size: 180112 bytes
Post-expand include size: 69761 bytes
Template argument size: 39760 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../a/s/p/Aspirin.html">http://en.wikipedia.org../../../a/s/p/Aspirin.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../a/r/t/Category%7EArticles_with_unsourced_statements_since_February_2007_f7dc.html" title="Category:Articles with unsourced statements since February 2007">Articles with unsourced statements since February 2007</a></span> | <span dir='ltr'><a href="../../../a/l/l/Category%7EAll_articles_with_unsourced_statements_2f67.html" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="../../../n/o/n/Category%7ENon-steroidal_anti-inflammatory_drugs_d9df.html" title="Category:Non-steroidal anti-inflammatory drugs">Non-steroidal anti-inflammatory drugs</a></span> | <span dir='ltr'><a href="../../../a/n/t/Category%7EAntiplatelet_drugs_df07.html" title="Category:Antiplatelet drugs">Antiplatelet drugs</a></span> | <span dir='ltr'><a href="../../../a/c/e/Category%7EAcetates_594a.html" title="Category:Acetates">Acetates</a></span> | <span dir='ltr'><a href="../../../b/e/n/Category%7EBenzoic_acids_1308.html" title="Category:Benzoic acids">Benzoic acids</a></span> | <span dir='ltr'><a href="../../../b/a/y/Category%7EBayer_brands_992c.html" title="Category:Bayer brands">Bayer brands</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../a/s/p/Aspirin.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../a/s/p/Talk%7EAspirin_d2fc.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Aspirin">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../ar/%D8%A3/%D8%B3/%D8%A8/%D8%A3%D8%B3%D8%A8%D8%B1%D9%8A%D9%86.html">العربية</a>
	      </li>
	      	      <li>
	      <a href="../../../../ast/a/s/p/Aspirina.html">Asturianu</a>
	      </li>
	      	      <li>
	      <a href="../../../../bg/%D0%B0/%D1%86/%D0%B5/%D0%90%D1%86%D0%B5%D1%82%D0%B8%D0%BB%D1%81%D0%B0%D0%BB%D0%B8%D1%86%D0%B8%D0%BB%D0%BE%D0%B2%D0%B0_%D0%BA%D0%B8%D1%81%D0%B5%D0%BB%D0%B8%D0%BD%D0%B0.html">Български</a>
	      </li>
	      	      <li>
	      <a href="../../../../ca/a/s/p/Aspirina.html">Català</a>
	      </li>
	      	      <li>
	      <a href="../../../../cs/k/y/s/Kyselina_acetylsalicylov%C3%A1.html">Česky</a>
	      </li>
	      	      <li>
	      <a href="../../../../da/a/s/p/Aspirin.html">Dansk</a>
	      </li>
	      	      <li>
	      <a href="../../../../de/a/c/e/Acetylsalicyls%C3%A4ure.html">Deutsch</a>
	      </li>
	      	      <li>
	      <a href="../../../../es/%C3%A1/c/i/%C3%81cido_acetilsalic%C3%ADlico.html">Español</a>
	      </li>
	      	      <li>
	      <a href="../../../../fa/%D8%A7/%D8%B3/%D8%AA/%D8%A7%D8%B3%D8%AA%DB%8C%D9%84_%D8%B3%D8%A7%D9%84%DB%8C%D8%B3%DB%8C%D9%84%DB%8C%DA%A9_%D8%A7%D8%B3%DB%8C%D8%AF.html">فارسی</a>
	      </li>
	      	      <li>
	      <a href="../../../../fr/a/c/i/Acide_ac%C3%A9tylsalicylique.html">Français</a>
	      </li>
	      	      <li>
	      <a href="../../../../gl/a/s/p/Aspirina.html">Galego</a>
	      </li>
	      	      <li>
	      <a href="../../../../ko/%EC%95%84/%EC%8A%A4/%ED%94%BC/%EC%95%84%EC%8A%A4%ED%94%BC%EB%A6%B0.html">한국어</a>
	      </li>
	      	      <li>
	      <a href="../../../../id/a/s/p/Aspirin.html">Bahasa Indonesia</a>
	      </li>
	      	      <li>
	      <a href="../../../../it/a/s/p/Aspirina.html">Italiano</a>
	      </li>
	      	      <li>
	      <a href="../../../../he/%D7%90/%D7%A1/%D7%A4/%D7%90%D7%A1%D7%A4%D7%99%D7%A8%D7%99%D7%9F.html">עברית</a>
	      </li>
	      	      <li>
	      <a href="../../../../lt/a/s/p/Aspirinas.html">Lietuvių</a>
	      </li>
	      	      <li>
	      <a href="../../../../hu/a/c/e/Acetilszalicilsav.html">Magyar</a>
	      </li>
	      	      <li>
	      <a href="../../../../ms/a/s/p/Aspirin.html">Bahasa Melayu</a>
	      </li>
	      	      <li>
	      <a href="../../../../nl/a/c/e/Acetylsalicylzuur.html">Nederlands</a>
	      </li>
	      	      <li>
	      <a href="../../../../ja/%E3%82%A2/%E3%82%B9/%E3%83%94/%E3%82%A2%E3%82%B9%E3%83%94%E3%83%AA%E3%83%B3.html">日本語</a>
	      </li>
	      	      <li>
	      <a href="../../../../no/a/c/e/Acetylsalisylsyre.html">‪Norsk (bokmål)‬</a>
	      </li>
	      	      <li>
	      <a href="../../../../nn/a/c/e/Acetylsalisylsyre.html">‪Norsk (nynorsk)‬</a>
	      </li>
	      	      <li>
	      <a href="../../../../pl/k/w/a/Kwas_acetylosalicylowy.html">Polski</a>
	      </li>
	      	      <li>
	      <a href="../../../../pt/a/s/p/Aspirina.html">Português</a>
	      </li>
	      	      <li>
	      <a href="../../../../ro/a/s/p/Aspirin%C4%83.html">Română</a>
	      </li>
	      	      <li>
	      <a href="../../../../ru/%D0%B0/%D1%86/%D0%B5/%D0%90%D1%86%D0%B5%D1%82%D0%B8%D0%BB%D1%81%D0%B0%D0%BB%D0%B8%D1%86%D0%B8%D0%BB%D0%BE%D0%B2%D0%B0%D1%8F_%D0%BA%D0%B8%D1%81%D0%BB%D0%BE%D1%82%D0%B0.html">Русский</a>
	      </li>
	      	      <li>
	      <a href="../../../../simple/a/s/p/Aspirin.html">Simple English</a>
	      </li>
	      	      <li>
	      <a href="../../../../sl/a/s/p/Aspirin.html">Slovenščina</a>
	      </li>
	      	      <li>
	      <a href="../../../../sr/%D0%B0/%D1%81/%D0%BF/%D0%90%D1%81%D0%BF%D0%B8%D1%80%D0%B8%D0%BD.html">Српски / Srpski</a>
	      </li>
	      	      <li>
	      <a href="../../../../fi/a/s/p/Aspiriini.html">Suomi</a>
	      </li>
	      	      <li>
	      <a href="../../../../sv/a/c/e/Acetylsalicylsyra.html">Svenska</a>
	      </li>
	      	      <li>
	      <a href="../../../../th/%E0%B9%81/%E0%B8%AD/%E0%B8%AA/%E0%B9%81%E0%B8%AD%E0%B8%AA%E0%B9%84%E0%B8%9E%E0%B8%A3%E0%B8%B4%E0%B8%99.html">ไทย</a>
	      </li>
	      	      <li>
	      <a href="../../../../tr/a/s/p/Aspirin.html">Türkçe</a>
	      </li>
	      	      <li>
	      <a href="../../../../uk/%D0%B0/%D1%86/%D0%B5/%D0%90%D1%86%D0%B5%D1%82%D0%B8%D0%BB%D1%81%D0%B0%D0%BB%D1%96%D1%86%D0%B8%D0%BB%D0%BE%D0%B2%D0%B0_%D0%BA%D0%B8%D1%81%D0%BB%D0%BE%D1%82%D0%B0.html">Українська</a>
	      </li>
	      	      <li>
	      <a href="../../../../zh/%E9%98%BF/%E5%8F%B8/%E5%8C%B9/%E9%98%BF%E5%8F%B8%E5%8C%B9%E6%9E%97.html">中文</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 16:51, 8 April 2007 by Wikipedia user Philiprogers. Based on work by Wikipedia user(s) <a href="../../../g/i/f/User%7EGiftlite_9506.html" title="User:Giftlite">Giftlite</a>, <a href="../../../f/v/a/User%7EFvasconcellos_4804.html" title="User:Fvasconcellos">Fvasconcellos</a>, <a href="../../../w/a/l/User%7EWalton_monarchist89_24d9.html" title="User:Walton monarchist89">Walton monarchist89</a>, Bbi5291, Rlcantwell, <a href="../../../j/o/h/User%7EJohn254_98f8.html" title="User:John254">John254</a>, <a href="../../../e/d/g/User%7EEdgar181_7e9b.html" title="User:Edgar181">Edgar181</a>, <a href="../../../d/e/l/User%7EDelirium_b0dc.html" title="User:Delirium">Delirium</a>, <a href="../../../a/n/t/User%7EAntiVandalBot_aa84.html" title="User:AntiVandalBot">AntiVandalBot</a>, Adamwpants, <a href="../../../z/z/u/User%7EZzuuzz_ab5e.html" title="User:Zzuuzz">Zzuuzz</a>, Daeshun1, <a href="../../../w/i/m/User%7EWimt_5387.html" title="User:Wimt">Wimt</a>, Hgrosser, <a href="../../../s/t/e/User%7EStephenb_2afe.html" title="User:Stephenb">Stephenb</a>, <a href="../../../s/o/n/User%7ESonjaaa_33fb.html" title="User:Sonjaaa">Sonjaaa</a>, Wikipodium, <a href="../../../b/e/e/User%7EBeetstra_df14.html" title="User:Beetstra">Beetstra</a>, <a href="../../../d/i/e/User%7EDieter_Simon_f22e.html" title="User:Dieter Simon">Dieter Simon</a>, <a href="../../../w/_/g/User%7EW_guice_dd47.html" title="User:W guice">W guice</a>, <a href="../../../d/j/_/User%7EDj_stone_6c95.html" title="User:Dj stone">Dj stone</a>, Miniyazz, <a href="../../../g/a/v/User%7EGaviidae_aa4a.html" title="User:Gaviidae">Gaviidae</a>, <a href="../../../s/e/l/User%7ESelket_adc6.html" title="User:Selket">Selket</a>, <a href="../../../a/h/o/User%7EAhoerstemeier_88c8.html" title="User:Ahoerstemeier">Ahoerstemeier</a>, <a href="../../../z/e/p/User%7EZeppelin4life_6840.html" title="User:Zeppelin4life">Zeppelin4life</a>, <a href="../../../m/a/c/User%7EMac_Davis_1c34.html" title="User:Mac Davis">Mac Davis</a>, <a href="../../../b/l/a/User%7EBlainster_3d88.html" title="User:Blainster">Blainster</a>, Papaya07, <a href="../../../c/a/p/User%7ECaptaindan_b048.html" title="User:Captaindan">Captaindan</a>, <a href="../../../z/e/t/User%7EZetawoof_384b.html" title="User:Zetawoof">Zetawoof</a>, <a href="../../../s/a/s/User%7ESasquatch_97db.html" title="User:Sasquatch">Sasquatch</a>, Robinatron, <a href="../../../b/f/e/User%7EBfesser_b737.html" title="User:Bfesser">Bfesser</a>, <a href="../../../e/l/_/User%7EEl_C_6d95.html" title="User:El C">El C</a>, Aghochikyan, <a href="../../../m/c/h/User%7EMchmike_e95d.html" title="User:Mchmike">Mchmike</a>, Fr33kman, <a href="../../../m/y/a/User%7EMyanw_4457.html" title="User:Myanw">Myanw</a>, <a href="../../../x/n/u/User%7EXnuala_1fc9.html" title="User:Xnuala">Xnuala</a>, <a href="../../../a/n/d/User%7EAndHab_5417.html" title="User:AndHab">AndHab</a>, <a href="../../../o/m/e/User%7EOmegatron_4264.html" title="User:Omegatron">Omegatron</a>, <a href="../../../c/o/r/User%7ECorpet_9014.html" title="User:Corpet">Corpet</a>, JTommy, <a href="../../../r/e/i/User%7ERei-bot_e279.html" title="User:Rei-bot">Rei-bot</a>, <a href="../../../s/m/a/User%7ESmackBot_cc7a.html" title="User:SmackBot">SmackBot</a>, <a href="../../../r/o/b/User%7ERobertknyc_49d5.html" title="User:Robertknyc">Robertknyc</a>, <a href="../../../s/t/e/User%7ESteveMcCluskey_1bdc.html" title="User:SteveMcCluskey">SteveMcCluskey</a>, <a href="../../../t/h/e/User%7EThe_Right_Honourable_73f1.html" title="User:The Right Honourable">The Right Honourable</a>, <a href="../../../s/g/d/User%7ESGDentarthurdent_9537.html" title="User:SGDentarthurdent">SGDentarthurdent</a>, <a href="../../../b/l/a/User%7EBlahity_985b.html" title="User:Blahity">Blahity</a>, <a href="../../../j/o/e/User%7EJoelmills_0f99.html" title="User:Joelmills">Joelmills</a>, <a href="../../../s/a/s/User%7ESashatoBot_1555.html" title="User:SashatoBot">SashatoBot</a>, <a href="../../../d/a/v/User%7EDavidruben_76a6.html" title="User:Davidruben">Davidruben</a>, <a href="../../../s/u/p/User%7ESupparluca_7508.html" title="User:Supparluca">Supparluca</a>, Spidra, Mlarocque, <a href="../../../t/h/i/User%7EThijs%21bot_bdf4.html" title="User:Thijs!bot">Thijs!bot</a>, <a href="../../../c/h/i/User%7EChill_doubt_fb3d.html" title="User:Chill doubt">Chill doubt</a>, <a href="../../../r/o/b/User%7ERobbot_3bd9.html" title="User:Robbot">Robbot</a>, <a href="../../../r/i/f/User%7ERifleman_82_610c.html" title="User:Rifleman 82">Rifleman 82</a>, <a href="../../../m/r/_/User%7EMr_Bungle_f8c8.html" title="User:Mr Bungle">Mr Bungle</a>, <a href="../../../m/a/p/User%7EMappychris_e48a.html" title="User:Mappychris">Mappychris</a>, <a href="../../../a/s/p/User%7EAspirin_OD_9fea.html" title="User:Aspirin OD">Aspirin OD</a>, <a href="../../../s/t/o/User%7EStone_0f5f.html" title="User:Stone">Stone</a>, Arbv777, YelmYelm, <a href="../../../d/i/s/User%7EDiscospinster_5902.html" title="User:Discospinster">Discospinster</a>, <a href="../../../r/a/v/User%7ERavik_7a00.html" title="User:Ravik">Ravik</a>, <a href="../../../y/a/n/User%7EYandman_f6bf.html" title="User:Yandman">Yandman</a>, Agjchs, <a href="../../../k/b/l/User%7EKblakes_8404.html" title="User:Kblakes">Kblakes</a>, <a href="../../../j/d/f/User%7EJdforresterBot_2d17.html" title="User:JdforresterBot">JdforresterBot</a>, <a href="../../../p/h/o/User%7EPhoebe_0992.html" title="User:Phoebe">Phoebe</a>, <a href="../../../r/e/e/User%7EReedy_Boy_3c7f.html" title="User:Reedy Boy">Reedy Boy</a>, <a href="../../../w/i/k/User%7EWiki_alf_522c.html" title="User:Wiki alf">Wiki alf</a>, <a href="../../../c/m/d/User%7ECmdrObot_0605.html" title="User:CmdrObot">CmdrObot</a>, <a href="../../../n/a/w/User%7ENawlinWiki_2ff5.html" title="User:NawlinWiki">NawlinWiki</a>, <a href="../../../d/a/n/User%7EDaniel.Bryant_22a1.html" title="User:Daniel.Bryant">Daniel.Bryant</a>, <a href="../../../o/h/p/User%7EOhpraisethelord_b6b3.html" title="User:Ohpraisethelord">Ohpraisethelord</a>, DrAlvi, <a href="../../../l/e/o/User%7ELeon7_48cb.html" title="User:Leon7">Leon7</a>, <a href="../../../t/h/i/User%7EThisischris_e628.html" title="User:Thisischris">Thisischris</a>, <a href="../../../w/a/r/User%7EWarpstarRider_35b7.html" title="User:WarpstarRider">WarpstarRider</a>, Stephthemedic, <a href="../../../m/r/b/User%7EMrbell_fcea.html" title="User:Mrbell">Mrbell</a>, <a href="../../../r/e/d/User%7ERedRollerskate_20f6.html" title="User:RedRollerskate">RedRollerskate</a>, <a href="../../../l/u/c/User%7ELucasbfr_3ae6.html" title="User:Lucasbfr">Lucasbfr</a>, X990, <a href="../../../c/o/d/User%7ECodex_Sinaiticus_4880.html" title="User:Codex Sinaiticus">Codex Sinaiticus</a>, <a href="../../../k/e/y/User%7EKeynes.john.maynard_97ea.html" title="User:Keynes.john.maynard">Keynes.john.maynard</a>, <a href="../../../l/u/n/User%7ELuna_Santin_1cab.html" title="User:Luna Santin">Luna Santin</a>, <a href="../../../m/a/k/User%7EMakemi_70a4.html" title="User:Makemi">Makemi</a>, Danallen46, <a href="../../../j/l/a/User%7EJlao04_59dd.html" title="User:Jlao04">Jlao04</a>, <a href="../../../i/r/i/User%7EIrishguy_9732.html" title="User:Irishguy">Irishguy</a>, <a href="../../../g/i/n/User%7EGinsengbomb_f4c8.html" title="User:Ginsengbomb">Ginsengbomb</a>, <a href="../../../k/s/h/User%7EKsheka_e2cf.html" title="User:Ksheka">Ksheka</a>, Jjz3d83, <a href="../../../d/i/g/User%7EDigital_Tsukasa_9073.html" title="User:Digital Tsukasa">Digital Tsukasa</a>, <a href="../../../l/e/e/User%7ELeeborkman_778f.html" title="User:Leeborkman">Leeborkman</a>, <a href="../../../f/r/e/User%7EFreplySpang_52d7.html" title="User:FreplySpang">FreplySpang</a>, <a href="../../../j/a/n/User%7EJAnDbot_5c44.html" title="User:JAnDbot">JAnDbot</a>, <a href="../../../n/i/c/User%7ENick_55c2.html" title="User:Nick">Nick</a>, <a href="../../../c/l/a/User%7ECladist_f28a.html" title="User:Cladist">Cladist</a>, <a href="../../../d/a/k/User%7EDakoman_902f.html" title="User:Dakoman">Dakoman</a>, <a href="../../../s/a/g/User%7ESagabot_42ff.html" title="User:Sagabot">Sagabot</a>, <a href="../../../b/e/n/User%7EBenjah-bmm27_ebae.html" title="User:Benjah-bmm27">Benjah-bmm27</a>, <a href="../../../k/a/i/User%7EKaiserbBot_1c36.html" title="User:KaiserbBot">KaiserbBot</a>, <a href="../../../n/i/s/User%7ENishkid64_5481.html" title="User:Nishkid64">Nishkid64</a>, Montanna, <a href="../../../s/h/u/User%7EShushruth_961b.html" title="User:Shushruth">Shushruth</a>, <a href="../../../d/v/d/User%7EDVD_R_W_e2d2.html" title="User:DVD R W">DVD R W</a>, <a href="../../../p/p/r/User%7EPproctor_c510.html" title="User:Pproctor">Pproctor</a>, <a href="../../../c/r/y/User%7ECryptoid_22a7.html" title="User:Cryptoid">Cryptoid</a>, <a href="../../../r/j/1/User%7ERJ1001_042c.html" title="User:RJ1001">RJ1001</a>, <a href="../../../i/v/a/User%7EIvanLanin_ebf1.html" title="User:IvanLanin">IvanLanin</a>, <a href="../../../o/h/n/User%7EOhnoitsjamie_fc14.html" title="User:Ohnoitsjamie">Ohnoitsjamie</a>, Tybalt01, Whiner01, <a href="../../../s/i/m/User%7ESimonD_82b9.html" title="User:SimonD">SimonD</a>, David wright, <a href="../../../a/r/c/User%7EArcadian_5c4b.html" title="User:Arcadian">Arcadian</a>, <a href="../../../g/y/a/User%7EGyan_5435.html" title="User:Gyan">Gyan</a>, <a href="../../../m/a/e/User%7EMaelor_975d.html" title="User:Maelor">Maelor</a>, <a href="../../../j/o/s/User%7EJosh_Grosse_d1d0.html" title="User:Josh Grosse">Josh Grosse</a>, <a href="../../../d/i/r/User%7EDirkvdM_f079.html" title="User:DirkvdM">DirkvdM</a>, <a href="../../../i/n/v/User%7EInvaderJim42_5d3f.html" title="User:InvaderJim42">InvaderJim42</a>, <a href="../../../i/x/f/User%7EIxfd64_14d3.html" title="User:Ixfd64">Ixfd64</a>, <a href="../../../a/m/i/User%7EAmiDaniel_52f1.html" title="User:AmiDaniel">AmiDaniel</a>, <a href="../../../b/u/i/User%7EBuickid_6b2b.html" title="User:Buickid">Buickid</a>, <a href="../../../%5E/d/e/User%7E%5Edemon.html" title="User:^demon">^demon</a>, <a href="../../../k/e/v/User%7EKevin_Breitenstein_8775.html" title="User:Kevin Breitenstein">Kevin Breitenstein</a>, <a href="../../../s/i/m/User%7ESimeon_H_8949.html" title="User:Simeon H">Simeon H</a>, <a href="../../../a/n/e/User%7EAnetode_cbff.html" title="User:Anetode">Anetode</a>, <a href="../../../w/o/l/User%7EWolfmankurd_678f.html" title="User:Wolfmankurd">Wolfmankurd</a>, <a href="../../../c/h/o/User%7EChobot_0dce.html" title="User:Chobot">Chobot</a>, <a href="../../../p/o/l/User%7EPollinator_822e.html" title="User:Pollinator">Pollinator</a>, <a href="../../../d/r/2E/User%7EDr.frog_7088.html" title="User:Dr.frog">Dr.frog</a>, <a href="../../../t/a/w/User%7ETawkerbot2_313a.html" title="User:Tawkerbot2">Tawkerbot2</a>, <a href="../../../f/o/u/User%7EFournax_5de0.html" title="User:Fournax">Fournax</a>, <a href="../../../j/o/s/User%7EJoshuagross_9d55.html" title="User:Joshuagross">Joshuagross</a>, <a href="../../../b/o/o/User%7EBooyabazooka_79a9.html" title="User:Booyabazooka">Booyabazooka</a>, <a href="../../../j/f/d/User%7EJfdwolff_9ea6.html" title="User:Jfdwolff">Jfdwolff</a>, <a href="../../../l/l/o/User%7ELlort_157f.html" title="User:Llort">Llort</a>, <a href="../../../a/v/i/User%7EAvigdor6_c128.html" title="User:Avigdor6">Avigdor6</a>, <a href="../../../p/a/u/User%7EPaul_012_98de.html" title="User:Paul 012">Paul 012</a>, <a href="../../../t/a/w/User%7ETaw_8bc0.html" title="User:Taw">Taw</a>, <a href="../../../g/o/l/User%7EGoldom_560d.html" title="User:Goldom">Goldom</a>, <a href="../../../j/o/e/User%7EJoeBot_e8e1.html" title="User:JoeBot">JoeBot</a>, <a href="../../../h/a/n/User%7EHanzolot_7e82.html" title="User:Hanzolot">Hanzolot</a>, <a href="../../../s/h/i/User%7EShizane_77d0.html" title="User:Shizane">Shizane</a>, <a href="../../../g/r/a/User%7EGraemeL_c5a8.html" title="User:GraemeL">GraemeL</a>, <a href="../../../n/a/c/User%7ENaconkantari_d810.html" title="User:Naconkantari">Naconkantari</a>, <a href="../../../j/r/a/User%7EJRawle_83db.html" title="User:JRawle">JRawle</a>, <a href="../../../m/a/i/User%7EMailer_diablo_6ffa.html" title="User:Mailer diablo">Mailer diablo</a>, <a href="../../../d/%C5%82/u/User%7ED%C5%82ugosz_4930.html" title="User:Długosz">Długosz</a>, <a href="../../../c/y/d/User%7ECyde_34b6.html" title="User:Cyde">Cyde</a>, Blonde2max, <a href="../../../b/i/l/User%7EBillFlis_4136.html" title="User:BillFlis">BillFlis</a>, <a href="../../../y/u/r/User%7EYurikBot_b393.html" title="User:YurikBot">YurikBot</a>, <a href="../../../g/a/b/User%7EGabbe_a391.html" title="User:Gabbe">Gabbe</a>, <a href="../../../p/e/r/User%7EPeruvianllama_baf8.html" title="User:Peruvianllama">Peruvianllama</a>, <a href="../../../e/a/s/User%7EEaster_Monkey_13f5.html" title="User:Easter Monkey">Easter Monkey</a>, <a href="../../../t/e/c/User%7ETechelf_1565.html" title="User:Techelf">Techelf</a>, <a href="../../../p/j/m/User%7EPJM_3604.html" title="User:PJM">PJM</a>, <a href="../../../c/h/o/User%7EChoess_95be.html" title="User:Choess">Choess</a>, <a href="../../../l/i/m/User%7ELimoWreck_58ea.html" title="User:LimoWreck">LimoWreck</a>, <a href="../../../e/w/l/User%7EEwlloyd_4a9d.html" title="User:Ewlloyd">Ewlloyd</a>, <a href="../../../y/a/m/User%7EYamamoto_Ichiro_b986.html" title="User:Yamamoto Ichiro">Yamamoto Ichiro</a>, <a href="../../../t/r/o/User%7ETrovatore_c393.html" title="User:Trovatore">Trovatore</a>, <a href="../../../m/c/e/User%7EMceder_5657.html" title="User:Mceder">Mceder</a>, <a href="../../../r/l/o/User%7ERlove_1468.html" title="User:Rlove">Rlove</a>, <a href="../../../s/n/u/User%7ESnurks_9a10.html" title="User:Snurks">Snurks</a>, <a href="../../../c/h/o/User%7ECholerashot_d396.html" title="User:Cholerashot">Cholerashot</a>, <a href="../../../p/e/a/User%7EPeak_ed3e.html" title="User:Peak">Peak</a>, <a href="../../../h/r/a/User%7EHraefen_512a.html" title="User:Hraefen">Hraefen</a>, Bluerhinos, <a href="../../../t/h/e/User%7EThesunisshining_b5d6.html" title="User:Thesunisshining">Thesunisshining</a>, <a href="../../../j/e/n/User%7EJengod_485b.html" title="User:Jengod">Jengod</a>, <a href="../../../k/a/i/User%7EKaiAdin_7f5a.html" title="User:KaiAdin">KaiAdin</a>, Harry Mudd, <a href="../../../h/u/r/User%7EHurricane111_4e5e.html" title="User:Hurricane111">Hurricane111</a>, <a href="../../../l/e/r/User%7ELeridant_7b6e.html" title="User:Leridant">Leridant</a>, <a href="../../../c/a/c/User%7ECacycle_6f2f.html" title="User:Cacycle">Cacycle</a>, <a href="../../../s/l/u/User%7ESlucas_1d1a.html" title="User:Slucas">Slucas</a>, <a href="../../../p/u/z/User%7EPuzzletChung_25e9.html" title="User:PuzzletChung">PuzzletChung</a>, <a href="../../../d/u/n/User%7EDuncan.france_d9ef.html" title="User:Duncan.france">Duncan.france</a>, <a href="../../../e/m/e/User%7EEmersoni_f854.html" title="User:Emersoni">Emersoni</a>, <a href="../../../e/v/e/User%7EEveryking_5c9e.html" title="User:Everyking">Everyking</a>, Kubra, <a href="../../../s/j/a/User%7ESjakkalle_011f.html" title="User:Sjakkalle">Sjakkalle</a>, <a href="../../../r/i/c/User%7ERichard_Arthur_Norton_%281958-_%29_421a.html" title="User:Richard Arthur Norton (1958- )">Richard Arthur Norton (1958- )</a>, <a href="../../../r/a/u/User%7ERaul654_54a3.html" title="User:Raul654">Raul654</a>, <a href="../../../j/f/u/User%7EJfurr1981_6930.html" title="User:Jfurr1981">Jfurr1981</a>, <a href="../../../e/i/g/User%7EEigenlambda_b228.html" title="User:Eigenlambda">Eigenlambda</a>, <a href="../../../t/i/t/User%7ETitoxd_5bc7.html" title="User:Titoxd">Titoxd</a>, <a href="../../../d/o/n/User%7EDonarreiskoffer_8624.html" title="User:Donarreiskoffer">Donarreiskoffer</a>, <a href="../../../s/u/b/User%7ESublium_83c6.html" title="User:Sublium">Sublium</a>, <a href="../../../j/o/a/User%7EJoanneB_e69b.html" title="User:JoanneB">JoanneB</a>, <a href="../../../a/n/d/User%7EAndrew_pmk_ab75.html" title="User:Andrew pmk">Andrew pmk</a>, <a href="../../../b/e/m/User%7EBemoeial_caf3.html" title="User:Bemoeial">Bemoeial</a>, <a href="../../../h/o/z/User%7EHoziron_a1d8.html" title="User:Hoziron">Hoziron</a>, <a href="../../../c/h/a/User%7EChairboy_157e.html" title="User:Chairboy">Chairboy</a>, Haoie, <a href="../../../d/i/d/User%7EDiderot_346d.html" title="User:Diderot">Diderot</a>, <a href="../../../a/c/e/User%7EAcegikmo1_4637.html" title="User:Acegikmo1">Acegikmo1</a>, <a href="../../../o/b/r/User%7EObradovic_Goran_8d03.html" title="User:Obradovic Goran">Obradovic Goran</a>, <a href="../../../d/i/r/User%7EDirus_30ce.html" title="User:Dirus">Dirus</a>, <a href="../../../l/t/-/User%7ELt-wiki-bot_96d3.html" title="User:Lt-wiki-bot">Lt-wiki-bot</a>, <a href="../../../a/s/h/User%7EAshley_Pomeroy_6ac2.html" title="User:Ashley Pomeroy">Ashley Pomeroy</a>, <a href="../../../m/a/n/User%7EMani1_e14b.html" title="User:Mani1">Mani1</a>, <a href="../../../n/e/u/User%7ENeutrality_7a9d.html" title="User:Neutrality">Neutrality</a>, Thesmallprint189, <a href="../../../r/o/c/User%7ERocastelo_9595.html" title="User:Rocastelo">Rocastelo</a>, <a href="../../../f/a/l/User%7EFalphin_2def.html" title="User:Falphin">Falphin</a>, <a href="../../../m/p/f/User%7EMPF_e17a.html" title="User:MPF">MPF</a>, <a href="../../../d/a/n/User%7EDanielCD_4f74.html" title="User:DanielCD">DanielCD</a>, <a href="../../../b/j/a/User%7EBjarteSorensen_ac43.html" title="User:BjarteSorensen">BjarteSorensen</a>, <a href="../../../i/c/e/User%7EIceKarma_ddee.html" title="User:IceKarma">IceKarma</a>, <a href="../../../d/z/h/User%7EDzhim_91dd.html" title="User:Dzhim">Dzhim</a>, Plegovini, <a href="../../../s/n/o/User%7ESnowdog_975b.html" title="User:Snowdog">Snowdog</a>, <a href="../../../a/l/e/User%7EAlex.tan_6c56.html" title="User:Alex.tan">Alex.tan</a>, <a href="../../../r/e/d/User%7ERedWordSmith_c15a.html" title="User:RedWordSmith">RedWordSmith</a>, <a href="../../../m/a/r/User%7EMarcika_111e.html" title="User:Marcika">Marcika</a>, <a href="../../../s/h/a/User%7EShanes_8450.html" title="User:Shanes">Shanes</a>, <a href="../../../h/a/h/User%7EHaham_hanuka_7d7e.html" title="User:Haham hanuka">Haham hanuka</a>, <a href="../../../e/l/b/User%7EElBenevolente_e171.html" title="User:ElBenevolente">ElBenevolente</a>, <a href="../../../d/o/d/User%7EDodonov_5be3.html" title="User:Dodonov">Dodonov</a>, <a href="../../../d/a/v/User%7EDavid_spector_3e6f.html" title="User:David spector">David spector</a>, <a href="../../../a/v/a/User%7EAvatar_9519.html" title="User:Avatar">Avatar</a>, <a href="../../../d/e/g/User%7EDeglr6328_f293.html" title="User:Deglr6328">Deglr6328</a>, <a href="../../../d/a/n/User%7EDan100_0edd.html" title="User:Dan100">Dan100</a>, <a href="../../../b/r/i/User%7EBrim_2417.html" title="User:Brim">Brim</a>, <a href="../../../c/e/n/User%7ECentrx_80e4.html" title="User:Centrx">Centrx</a>, <a href="../../../r/o/p/User%7ERopers_35d3.html" title="User:Ropers">Ropers</a>, <a href="../../../s/i/m/User%7ESimonP_1010.html" title="User:SimonP">SimonP</a>, <a href="../../../g/e/n/User%7EGeni_1ef9.html" title="User:Geni">Geni</a>, <a href="../../../a/l/e/User%7EAlexanderWinston_529b.html" title="User:AlexanderWinston">AlexanderWinston</a>, <a href="../../../a/x/e/User%7EAxelBoldt_4306.html" title="User:AxelBoldt">AxelBoldt</a>, <a href="../../../s/h/a/User%7ESharkford_f0aa.html" title="User:Sharkford">Sharkford</a>, <a href="../../../o/l/a/User%7EOlaf_Fritz_96ff.html" title="User:Olaf Fritz">Olaf Fritz</a>, Gromit, <a href="../../../e/e/q/User%7EEequor_b13d.html" title="User:Eequor">Eequor</a>, DanMatan, <a href="../../../s/v/e/User%7ESverdrup_2f1f.html" title="User:Sverdrup">Sverdrup</a>, <a href="../../../s/a/r/User%7ESarge_Baldy_6bdd.html" title="User:Sarge Baldy">Sarge Baldy</a>, <a href="../../../r/a/n/User%7ERandom832_2ea5.html" title="User:Random832">Random832</a>, <a href="../../../y/o/s/User%7EYosri_d93e.html" title="User:Yosri">Yosri</a>, <a href="../../../g/u/a/User%7EGuanaco_98c8.html" title="User:Guanaco">Guanaco</a>, <a href="../../../d/u/k/User%7EDukeofomnium_095c.html" title="User:Dukeofomnium">Dukeofomnium</a>, <a href="../../../s/p/e/User%7ESpencer195_dc2c.html" title="User:Spencer195">Spencer195</a>, <a href="../../../n/u/n/User%7ENunh-huh_d05a.html" title="User:Nunh-huh">Nunh-huh</a>, <a href="../../../w/m/a/User%7EWmahan_ede0.html" title="User:Wmahan">Wmahan</a>, <a href="../../../d/a/v/User%7EDavid.Monniaux_7db1.html" title="User:David.Monniaux">David.Monniaux</a>, <a href="../../../b/o/r/User%7EBorislav_1944.html" title="User:Borislav">Borislav</a>, Michael Paiewonsky, <a href="../../../c/m/k/User%7ECmkpl_4bd0.html" title="User:Cmkpl">Cmkpl</a>, <a href="../../../s/a/m/User%7ESamw_5671.html" title="User:Samw">Samw</a>, <a href="../../../p/o/s/User%7EPostdlf_dca8.html" title="User:Postdlf">Postdlf</a>, <a href="../../../m/a/t/User%7EMatthew_Stannard_9e17.html" title="User:Matthew Stannard">Matthew Stannard</a>, <a href="../../../d/j/_/User%7EDJ_Clayworth_c4dc.html" title="User:DJ Clayworth">DJ Clayworth</a>, <a href="../../../t/o/p/User%7EToph99_3729.html" title="User:Toph99">Toph99</a>, <a href="../../../e/m/p/User%7EEmperorbma_7b7a.html" title="User:Emperorbma">Emperorbma</a>, <a href="../../../d/e/r/User%7EDersonlwd_b8cb.html" title="User:Dersonlwd">Dersonlwd</a>, <a href="../../../w/i/k/User%7EWikibot_9002.html" title="User:Wikibot">Wikibot</a>, <a href="../../../m/i/n/User%7EMinesweeper_5696.html" title="User:Minesweeper">Minesweeper</a>, <a href="../../../l/l/u/User%7ELlull_fbf8.html" title="User:Llull">Llull</a>, <a href="../../../k/r/i/User%7EKristof_vt_ae18.html" title="User:Kristof vt">Kristof vt</a>, <a href="../../../c/h/r/User%7EChristian_3dad.html" title="User:Christian">Christian</a>, <a href="../../../p/a/n/User%7EPanoramix_920b.html" title="User:Panoramix">Panoramix</a>, <a href="../../../a/r/t/User%7EArteitle_8e78.html" title="User:Arteitle">Arteitle</a>, <a href="../../../t/o/p/User%7ETopory_0c3a.html" title="User:Topory">Topory</a>, <a href="../../../m/a/v/User%7EMaveric149_24ee.html" title="User:Maveric149">Maveric149</a>, <a href="../../../e/d/d/User%7EEddEdmondson_c61e.html" title="User:EddEdmondson">EddEdmondson</a>, <a href="../../../s/n/o/User%7ESnoyes_3ec6.html" title="User:Snoyes">Snoyes</a>, <a href="../../../a/n/d/User%7EAndre_Engels_23d0.html" title="User:Andre Engels">Andre Engels</a>, <a href="../../../t/h/e/User%7EThe_Anome_61a9.html" title="User:The Anome">The Anome</a> and <a href="../../../t/e/d/User%7ETed_Longstaffe_d419.html" title="User:Ted Longstaffe">Ted Longstaffe</a> and Anonymous user(s) of Wikipedia.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
